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ABSTRACT
Neonatal mice have immature immune systems with defects in several
components of inflammatory, innate, and specific immune responses and develop a
preferential T helper type 2 (Th2) response following immunization with many vaccine
antigens. Although maternal antibody is the major form of protection from disease in
early life when the neonatal immune system is stil immature, the presence of maternal
antibody also interferes with active immunization, placing infants at risk for severe
bacterial and viral infection. Recent studies have suggested that immunizing with DNA
plasmids encoding the vaccine antigen of interest is highly efficacious in a variety of
adult animal models. However, similar extensive studies have not been conducted in
infants. In this dissertation, we examine both the quantitative and qualitative differences
between neonatal and adult humoral and cell-mediated immune responses in the presence
or absence of maternal antibody.
First, we wished to determine if one-day-old neonatal mice immunid with
plasmid DNA expressing influenza NPR/8/34 hemagglutinin (HA) by either
intramuscular (Lm. ) or gene gun (g. g.) inoculation were capable of generating humoral
responses comparable to those in mice immunizd as adults. We found that newborn
mice developed stable, long- lived , protective anti-HA-specific IgG responses similar in
titer to those of adult DNA- immunized mice. However, unlie the adult Lm. and g.
DNA immunizations, which develop polarized IgG2a and IgG 1 responses, respectively,
mice immunized as neonates developed a variety ofIgGl- , IgG2a- , and mixed
IgG l/IgG2a responses regardless of the inoculation method. Boosting increased, but did
not change these antibody profies. We also found that, in contrast to the DNA
immunizations , inoculations of newborn mice with an NPR/8/34 viral protein subunit
preparation failed to elicit an antibody response. Further, temporal studies revealed that
both responsiveness to protein vaccination and development of polaized patterns of 
help following DNA immunization appeared by 2 weeks of age.
To determine if the disparity of polarized IgG responses between neonatal and
adult DNA vaccinated mice was due to deficiencies in Thl promoting cytokines, we
addressed the abilty of DNA encoding Thl cytokies to bia the isotype of antibody
raisd by neonatal DNA immunization. We found that neonatal mice coimmunized with
HA and either IL- 12 or IFNy-expressing DNAs developed IgG2a-biased immune
responss, regardless of inoculation method, whereas these DNAs had no effect on IgG
subtype patterns in adult DNA immunized mice. Consistent with the Thl-promoting
effects of these cytokies, we also observed that codelivery oflL- 12 or IFNy DNAs
raisd T helper responses toward Thl in mice immunized both as neonates or adults.
Thus, codelivery of cytokine DNAs may be effective at taioring immune responses
depending on the required correlates of protection for a given pathogen.
Finally, we addressed the effect of maternal antibody on the elicitation of humoral
and cell-mediated immune responses. We tested the abilty of Lm. and g.g. immunization
with DNA expressing influenza HA and/or nucleoprotein (NP) to raise protective
vii
humoral and cellular responses in the presence and absence of maternal antibody. 
found that neonatal mice born to influenza-immune mothers raised full antibody
responses to NP but failed to generate antibody responses to HA In contrast, the
presence of maternal antibody did not affect the generation of long-lived CD4+ and
CD8+ T cell responses to both HA and NP. Thus, maternal antibody did not affect cell-
mediated responses, but rather it liited humoral responses, with the abilty to limit the
antibody response correlating with whether the DNA-expressed immunogen was
localized in the plasma membrane or within the cell. We further observed that protection
from influenza virus challenge was dependent on the presence of anti-HA IgG and was
independent of the presence T cell responses.
Taken together with other publihed studies, the data presented in this disserttion
help better characteriz the responses elicited by DNA vaccines at birth. This dissertation
presents several novel observations including the temporal development of polarized IgG
subtype responses, the abilty of codelivered Thl cytokine DNA to affect both antibody
and T cell responses in the neonate, and the abilty to generate humoral responses to
intracellular, but not plasma membrane proteins, in the presence of maternal antibody.
Furthermore, the data provides rationale for further development of DNA vaccines in the
neonate.
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INTRODUCTION
INTRODUCTION
Vaccines have profound and long lasting effects on world health. Small pox has
been eradicated, polio is near elimination, and diseases such as diphtheria, measles
mumps, pertusis, and tetanus are contained. Nonetheless, microbes remain major kilers,
with current vaccines addressing only a handful of the infections of man. Common
infectious diseases for which there are no vaccines cost the United States $120 bilion per
year (Robinson et ai. 1997b). In fIrst world countries, emerging infections such as
immunodeficiency virses, as well as reemerging diseases lie drug-resistant forms of
tuberculosis, pose new threats and challenges for vaccine development. The need for
both new and improved vaccines is even more pronounced in third world countries where
effective vaccines are often unavailable or cost-prohibitive.
The need for new and improved vaccines is highlighted by statistics of infant
mortality rates. There have been overall significant improvements in rates of child
survival over the past 20-30 years. This is due to several factors including improvements
in living conditions, such as water supplies, sanitation and nutrition, as well as the
healthcare improvements such as the Expanded Programme of Immunization (EPI). The
EPI has had a profound effect on infant mortality rates due to the effects of both measles
and pertussis vaccines. Nevertheless, infant mortality remains high. For instance, of the
approximately 126 milion live birhs in 1995, 8 millon died within the fIrst year
(Mulholland, 1998). The development of safe and effective immunization protocols is
paricularly challenging due to the unique profie of the immature neonatal immune
system. Recently, promise for the development of new vaccines has been realized with
the discovery that direct injections of antigen-expressing DNAs can initiate protective
immune responses. However, the effcacy of these novel vaccines in infants remains to
be characterized.
DNA-based vaccines use bacterial plasmids to express protein immunogens in
vaccinated hosts. Recombinant DNA technology is used to clone cDNAs encoding
immunogens of interest into eukaryotic expression vectors. Vaccine plasmids are then
amplifed in bacteria, purifed, and directly inoculated into the hosts being vaccinated.
DNA can be inoculated by a needle injection of DNA in salie, or by a gene gun device
which delivers DNA-coated gold beads into the skin (Figure 1). Plasmid DNA is taken
up by host cells, the vaccine protein is expressed, processed and presented in the context
of self-MHC class I (MHC I) and MHC class II (MHC II) molecules, and an immune
respons against the DNA-encoded immunogen is generated.
PLASMID VECTORS AND DELIVERY
At least part of the efficacy of DNA-based vaccines can be attributed to the abilty
of plasmid DNA to serve as an adjuvant as well as the source of the encoded immunogen
(Sato et al., 1996). This adjuvant activity appears to be a general property ofCpG motifs
(5' - purine- purine- G- pyrimidine- pyrimidine- 3' ) in bacterial-derived DNA (for reviews,
se (Krieg et ai., 1998b; Pisetsky, 1996). CpG motifs in bacterial DNA distinguish
themselves from those in eukaryotic DNAs both by being unmethylated and more
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Figure 1. Schematic for the construction, purication and inoculation of a DNA vaccine.
frequent. In certain nucleotide sequence contexts, termed CpG-stimulatory (CpG-S),
CpG sequences trigger innate immune defenses, the production of Thl cytokines, and the
activation of dendritic cells (Jakob et ai., 1998; Krieg et al., 1998a; Krieg et al., 1998b).
These innate responses synergize with acquired immune responses against the DNA-
expressed protein. In other base contexts, termed CpG-neutralzing (CpG-N), CpG
sequences inhibit activation of innate immune responses, potentially providing a
mechanism for a microbe to evade host immune defenses. CpG-N sequences are over-
represented in the human genome, where they are 2-5 times more frequent than CpG-
motifs (Krieg et al., 1998a).
The manipulation of CpG-S and CpG-N sequences in vaccine vectors can
improve the effcacy of immunization (Krieg et ai., 1998a). For example, in a vector that
contaied 254 CpG dinucleotides, of which 134 are CpG- N, the mutation of 56 of the
CpG-N motifs increased the abilty to rais antibody - fold and cytotoxic T lymphocyte
(CTL) lysis from 30- to 40%. Adding CpG-S sequences to the CpG-N mutated vector
further increased antibody responses - fold , but did not affect CTL activity.
In vitro studies on the immunostimulatory activity of CpG DNA reveal the CpG-
motifs activate cells through both the NFKB and AP- l signaling pathways (Yi et al.,
1996; Yi and Krieg, 1998). Activation of both NFKB and API are required for CpG-
mediated cytokie induction. Chloroquine, an inhibitor of endosomal acidification
selectively abolishes the activation of both pathways and appears to block a very early
event in the signaling triggered by CpG DNA (Yi et ai. , 1996).
The two most broadly used approaches to DNA delivery are injection of DNA in
salie using a hypodermic needle or gene gun delivery of DNA-coated gold beads.
Salie injections deliver DNA into extracellular spaces, whereas gene gun deliveries
bombard DNA directly into cells. The salie injections require much larger amount of
DNA (100- 1000 times more) than the gene gun (Fynan et al., 1993). These two types of
delivery also differ in that salie injections bias responses towards type 1 T cell help,
whereas gene gun deliveries bias responses to type 2 T cell help (Feltquate et al., 1997;
Pertmer, Roberts, and Haynes, 1996).
ADVANTAGES OF USING DNA VACCINES AS COMPARED WITH
CONVENTIONAL METHODS OF V ACCINA TION
DNA-based immunizations have a number of advantages, as well as
disadvantages, over more classical methods of immunization. The major immunological
advantage is the abilty of the immunogen to be presented by both MHC class I and class
II molecules. Endogenously synthesized proteins readily enter the processing pathway
for the loading of peptide epitopes onto both MHC I and MHC II molecules. MHC 
presented epitopes raise CTL responses whereas MHC II-presented epitopes raise helper
T cell (Th). When compared with live attenuated vaccines or recombinant viral vectors
that produce immunogens in cells that raie both Th and CTL, DNA vaccines have the
advantages of not being infectious and of focusing the immune response on only those
antigens desired for immunization. DNA vaccines also have the advantage that they can
be manipulated relatively easily to raie type 1 or type 2 T cell help. This allows a
vaccine to be tailored for the type of immune response that wil be mobilized to combat
infection. DNA vaccines are cost effective due to the ease with which plasmids can be
constructed using recombinant DNA technology, the abilty to use a generic method for
vaccine production (growth and purication of plasmid DNA), and the stabilty of DNA
over a wide range of temperatures. Overall, disadvantages of DNA vaccines include the
limitation of immunizations to protein immunogens, the potential for atypical processing
of bacterial and parasitic proteins by eukaryotic cell, the production of anti-DNA
antibodies, and the possibilty of vaccine vector integration into chromosomal DNA.
Infant DNA immunization may cause additional problems. Integration could pose a
paricular threat when introduced into the genome of rapidly dividing cells,in infants.
Additionally, deliberate alterations in the Thl/Th2 balance in infants may eventually lead
to immunopathological responses (e.g., such as those seen following the initial trials of
inactivated respiratory syncytial virs) (Siegrist et al., 1997). The induction of tolerance
to the vaccine antigen may also be possible (Mor et al., 1996).
MECHANISTIC BASIS FOR DNA-RAISED IMMUNE RESPONSES
DNA vaccines generate immune responses with nanogram levels of expressed
protein. DNA vaccines are liely effcacious due to the high effciencies of antigen
presentation that are achieved by the direct transfection of professional antigen presenting
cells (Banchereau and Steinman, 1998; Casares et ai. 1997; Condon et al., 1996;
Porgador et ai., 1998). The adjuvant activity of unmethylated CpG sequences in plasmid
DNA also may contribute to the efficacy of DNA vaccines (Klinman, Yamshchikov, and
Ishigatsubo, 1997) (see above).
Antigen Presentation by Bone Marrow-Derived Cells. The fIrmest knowledge as to how
DNA vaccines work comes from studies using chimeric mice. These studies demonstrate
that antigen presentation is by bone marrow-derived cells. Bone marrow-derived cells
include the dendritic cells, macro phages, and B cells that are specialized for antigen
presentation and termed professional antigen presenting cells (APC). For studies on
antigen presentation, Fl mice were bred and their bone marows destroyed by iradiation.
The iradiated mice were reconstituted with the marow of one parent, immunized, and
tested for MHC-restriction of the raised CTL response. Following both gene gun and
Lm. immunizations, the haplotype specificity of the raised CTL response was restricted to
that of the reconstituting marow (Corr et al., 1996; Fu et ai., 1997; Iwasaki et ai.,
1997b). This restriction held in the presence of cotransfected DNAs expressing the B7
co stimulatory molecule or GM-CSF plus IL- 12 (Iwasaki et al., 1997). Thus, the addition
of molecules that are associated with antigen presentation to keratinocytes or muscle cells
was not suffcient to support antigen presentation.
The site of antigen presentation and the nature of the antigen presenting cell have
been tracked further using reporter plasmids and sorted cell. Following gene gun
immunizations, reporter plasmid-bearing epidermal Langerhans cells migrate to the
draining lymph node (Porgador et al. 1998; Condon et ai., 1996), where they present
antigen (Porgador et al., 1998). Approximately 60 directly transfected epidermal
Langerhans-derived dendritic cells were observed in the draining lymph node following
delivery of four gene gun shots to the abdominal skin (Porgador et al. 1998). Epidermal
Langerhans cells constitute bout 8% of the cells in the skin. Thus, direct transfection of
these cells by gene gun bombardment of DNA would be expected. Following Lm. salie
injections of DNA, dendritic cells in the draining lymph node also have been found to
carry vaccine DNA and present antigen (Casares et al., 1997). Approximately 0.4% of
the dendritic cells in the draining node were estimated to be presenting antigen following
Lm. DNA immunizations (Casares et ai., 1997). Given that the number of dendritic cells
in a lymph node range from 15,000-40,000, this would suggest that between 60- 160
directly tranfected APC are present in the draining nodes of Lm. inoculated mice.
Studies using GFP-expressing plasmids have localized GFP-expressing cells in the
peripheral blood (Chattergoon et al. 1998). These cells, which were identifed as
macrophages, coexpressed CD80 and CD86 and were hypothesized to be able to induce T
cell responses. In this last study, GFP-expressing cells in the draining node were
identifed as macrophages rather than dendritic cell. In all of the studies on the
localization of antigen presenting cell in the lymph node, transfected cells have been
clustered. This clustering has been hypothesized to reflect the draiage pattern of the
inoculated site into the node.
Cross-priming of dendritic cells or macro phages also contributes to antigen
presentation. Cross-priming occurs when a bone marrow-derived cell (such as a dendritic
cell) presents peptides derived from proteins synthesized in another cell (Carbone and
Bevan, 1990). Cross-priming has been demonstrated to prime CD8+ CTL responses
following injection oftransfected myoblasts (Ulmer, Donnelly, and Liu , 1996). Cross-
priming has been demonstrated in i.m. immunization of SCID mice subsequently infused
with a competent bone marrow (Doe et ai. 1996). In these experiments, the addition of
bone marrow as late as 21 days after Lm. immunization resulted in the raising of CTL.
This implies that factories of antigen last for several weeks. Following gene gun
immunization, the temporal dependence of CTL responses on the skin target site suggest
that cross-priming is important for the realization of a full primary response (Torres et ai.,
1997). However, in another study, cross-priming did not appear to playa major role in
the elicitation of CD8+ CTL following gene gun DNA immunization (Porgador et al.,
1998).
Role of the Target Site. The skin and muscle targets of DNA delivery play different
roles in the initiation of DNA-raised immune responses. The highest density of
transfected cells are found at the sites of DNA delivery, with the most frequent
expressing cells in the skin being keratinocytes (Eisenbraun, Fuller, and Haynes, 1993;
Hengge et ai., 1995; Raz et al., 1994), and in muscle, striated muscle cells (Davis,
Whalen, and Demeneix, 1993; Wolff et al., 1990). Temporal ablation studies of gene
gun-bombarded skin revealed that the skin plays an essential role in the mounting of both
j)j
antibody and CTL responses (Klman et al., 1998; Torres et ai. 1997). By contrast
ablation of the muscle target revealed both antibody and CTL responses being
independent of the injected muscle within minutes of DNA delivery (Torres et al. , 1997).
These two different patterns of target site dependence held for DNAs that expressed
plasma membrane, secreted , or intracellular antigen (Torres et ai. 1997). Transplantation
of the gene gun target site revealed that cells capable of inducing a primary antibody
response moved out of the skin within 12 hours, but that sedentar as well as the mobile
cell were required for the full antibody response (Kliman et ai. 1998). Secondary gene
gun-raised antibody and Th responses appeared to be entirely mediated by cells that
moved out of the target site within 12 hours (Klman et al., 1998). These results suggest
that following gene gun inoculations, both directly transfected epidermal Langerhans
cell and antigen expression by keratinocytes contribute to the primary responses,
whereas directly transfected Lagerhans cells are sufficient for the stimulation of the
seondary responses. They also suggest that following Lm. immunization, the
immunologically important tranfection events occur at distal sites or in trafficking
lymphoid cells. The rapid spread of Lm. inoculated DNA throughout the body would
faciltate distal tranfections, especially in lymphoid organ that f1ter blood and lymph.
Why skin and not muscle serves as a factory for antigen is not clear. However, the skin is
much more heavily populated by dendritic cells than muscle, with localized dendritic
cell potentially supporting the uptake and presentation of locally produced antigen.
Maintenance of the Immune Response. A characteristic of DNA-raised immune
responses is the generation of effective memory. Normal mechanisms for the
development of immunological memory as well as unique aspects of DNA-based
immunization are likely to contribute to this phenomenon. An immunological
mechanism for sustaining the viability and differentiation of activated B cell is the
display of antigen-antibody complexes by follcular dendritic cells (FDC). FDC are
non-bone marrow-derived cells that reside in the germinal centers of lymph nodes and
display both Fc and complement receptors (Banchereau and Steinman, 1998; Liu et ai.
1996). These cells are potent stimulators ofB cells. A second type of germinal center
dendritic cell can serve as a potent stimulator ofT cells (Grouard et al., 1996). Following
both gene gun and i.m. deliveries of DNA, antigen presentation occurs for several weeks
(Doe et ai., 1996; Boyle and Robinson, 2000). This length of time for antigen
presentation overlaps the appearance of generated antibody. Thus, there is the potential
for the generation of FDC-displayed immune-complexes between the newly appearing
antibody and the stil expressed antigen. This phenomenon could account for the abilty
of single DNA immunizations to raie long lasting memory responses. In mice, these
long lasting memory responses are frequently accompanied by the persistence of
antibody.
IMMUNE RESPONSES RAISED BY DNA VACCINES
T cell Help
Background. One of the unique features of DNA vaccines is the relative ease with which
immunizations can be manipulated to bias the type of raised T cell help towards type 1 or
type 2 (Feltquate et ai., 1997). The type ofT cell help that supports an immune response
determines whether the raised antibody wil be C' -dependent and phagocyte-mediated
defenses wil be mobilized (a type 1 response), or whether the raised antibody wil be
C' - independent and phagocyte-independent defenses wil be mobilzed (a type 2
response) (Figure 2) (for reviews, see Fearon and Locksley, 1996; Seder and Paul, 1994;
Ward, Bacon, and Westwick, 1998). Each of these types of responses are associated with
Th and CTL cells with distinctive patterns of lymphokine and chemokine expression that
support specific rearangements of Ig genes, patterns of lymphocyte trafficking, and types
of innate immune responses. Signature lymphokines and chemokines for Thl cells
include IFN-y and RATES , and for Th2 cells, IL-4 and eotaxin. Historically type 1
responses have ben associated with the raising of cytotoxic T cell and type 2 responses
with the taising of antibody. These associations arose at least in part from the historical
use of infections, which undergo endogenous synthesis and the loading of MHC I, to
rais type 1 responses; and the use of inactivated viruses or protein subunits, which do
not undergo endogenous synthesis and do not load MHC I, to rai type 2 responses.
With the advent of DNA vaccines, endogenous expression of antigens and the loading of
MHC I antigens became possible under conditions that raise type 2 as well as type 1
responses. Thus, the abilty to study type 2 responses that raie CTL as well as antibody
became possible. At present, relatively little is understood about the frequency and types
ofCTL raisd by DNA immunizations (see below). However, it is clear that both
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antibody and CTL are supported by type 1 (Ulmer et al., 1993) as well as type 2
(Pertmer, Roberts, and Haynes, 1996) T cell help.
Raising of different types of T cell help. Both the method of DNA delivery and the
expressed immunogen affect the predominant type ofT cell help that is raised by a DNA
immunization (Figure 3). In general, saline injections of DNA raise immune responses
that are biased towards type 1 help, whereas gene gun deliveries raise immune responses
that are biased towards type 2 help (Feltquate et al., 1997; Pertmer, Roberts, and Haynes
1996). These patterns of raised help hold for intracellular and plasma membrane-bound
forms of DNA-expressed antigens and are determined by the method and not the route of
inoculations (Feltquate et al., 1997). However, for secreted antigens, both im. and gene
gun inoculations tend to raie type 2 help (Torres et ai., 1999; Boyle, Koniaras, and Lew,
1997; Haddad et ai., 1997; Lewis et ai. 1997; Sallberg et ai., 1997). The Th-biased
response raised by secreted antigens is the same type of response observed for inoculated
proteins. Some exceptions to these generalizations have ben reported. For example,
Thl-biased responses are raised by a secreted form of the hepatitis C nucleocapsid
protein (Inchauspe, 1997). Alo, some MHC backgrounds give IgGI predominant
Th2-biased responses for al methods of antigen delivery (Sallberg et al., 1997).
Th1-biased responseCeed 
Th mix reponses
. Seed 
Th-biase responseCeed 
. Seed 
Figure 3. Two different types ofT cell help and the associated antibody and innate
immune responss in mice
,1:
For most DNA-raisd responses, the type of raised T cell help is stable over time.
Furthermore, the type of the DNA-primed help is maintained in the face of challenge
infections or subs quent immunizations that would raise the opposite type of help in a
naive animal (Feltquate et ai. 1997; Pertmer, Roberts, and Haynes, 1996). For example,
when a Th2-primed response undergoes challenge with a Thl viral infection, the
anamnestic response retains the Th2-type of the prime (FeUquate et al., 1997). An
example where the type of help has changed with time is the malaria circumsporozoite
protein, where an initial type I-biased response changed to type 2 over the fIrst month of
immunization (Mor et ai. , 1995).
Mechanistic basis for different types of T cell help. The mechanism by which diferent
methods of DNA immunization, or form of DNA-expressed antigens, raise different
types of T cell help is not understood. Our bias is that differences in the nature, or
differentiated state of antigen presenting cells determine the type ofT cell help.
Dendritic cells can differentiate to become either IL- 12 secreting, which would support
the development of Thl cells, or IL-4 secreting, which would support the differentiation
ofTh2 cell (Banchereau and Steinman, 1998). Sale injections result in DNA
undergoing endocytosis, a process that stimulates dendritic cell to differentiate for the
production ofThl cytokines (Jakob et ai., 1998; Yi and Krieg, 1998) (se above). Gene
gun deliveries bombard DNA directly into cells, thus bypassing this Thl-stimulating
endocytic step. An influence of APC on the type of raised response is suggested in
neonatal immunizations in mice, where the polarization of responses into the patterns
observed for adult DNA immunizations occurs over the same developmental time course
as the appearance of markers characteristic of mature APC (Pertmer and Robinson
1999).
A popular hypothesis as to why Lm. immunizations raise Thl-biased immune
responses is that the lage amounts of DNA used for these immunizations trigger type 1
help (see above). Tests of this hypothesis for a membrane associated antigen have
revealed no difference in the type of response raised by different doses of DNA
(Feltquate et ai., 1997). However, for a sereted antigen, larger doses of DNA can move
a Th2-biased response toward a Thl-bias (S. Johnston, personal communication). This is
consistent with the Thl adjuvant activity of CpG sequences for protein immunizations
DNA (for reviews, see Krieg et al., 1998b; Pisetsky, 1996).
Practical uses of polarized T cell help. The abilty to polaize T cell help by DNA-based
immunizations has ben applied to precliical models for allergy and autoimmune
diseass. In allergy, the goal has ben to shif the allergic Th2 response (and the
associated production of IgE) to non-allergic Thl responses. In autoimmune disease, the
goal has been to shif the response from a self-destructive Thl response to a
non-destructive Th2 response. In both models, pre-disease priming of responses for the
desired Th type has prevented or ameliorated the induction of disease (Waisman et ai.,
1996). Shifing the pattern ofT cell help for established disease has also had some
success (Raz et ai., 1996). Finally, using DNA vaccines to circumvent Th2-biased
immune responses in neonates is currently being explored (Kovarik et ai. 1999); (see
below). The long term importance of the abilty to tailor the type of T cell help for
microbial vaccines remains to be explored.
Cvtotoxic T cells
A forte of DNA vaccines is the abilty to raie CTL. Most analyses for
DNA-raised CTL have been done in bulk assays following in vivo or in vitro
restimulation. However, more recently, limiting dilution analyses have been undertaken
to more rigorously defme precursor frequencies. These analyses reveal similar
frequencies ofCTL raised by Ln. immunizations with Sendai virus and gene gun DNA
immunizations (Chen, Webster, and Woodland, 1998). Similar frequencies ofCTL were
also observed following Lm. immunization with a ubiquitinated minigene for LCMV and
intraperitoneal (Lp. ) immunizations with the Armstrong strai of LCMV (Rodriguez
Zhang, and Whitton, 1997). In the Sendai model, similar frequencies of responses were
mounted to dominant and subdominant epitopes by the DNA immunization and the
natural infection (Chen, Webster, and Woodland, 1998). In the influenza model, LDA
showed similar NP-specifc CTL precursor frequencies in mice im. immunized with NP
DNA or Ln. infection with influenza virus (Fu et ai., 1999). In the LCMV model, the T
cell receptors on the DNA-raised and infection-raised CTL had similar affmities as
measured by the ability to lyse targets coated with from 0. 1 nm to 1000 nm peptide
(Rodriguez, Zhang, and Whitton, 1997).
Studies in the LCMV model have revealed DNA-raised CTL causing
immunopathology as well as protection (Zarozinski et ai., 1995). In these studies, a
suboptimal nucleoprotein-expressing DNA vaccine raised precursor frequencies of - 1 in
000. Upon challenge with the Armstrong strain of virus, some mice had accelerated
disease, whereas others were protected. The Armstrong strai of LCMV does not kil
infected cells. Thus, disease enhancement presumably reflected the CTL not controlling
the LCMV infection suffciently to prevent spread of virs and consequent widespread
destruction of cells by CTL.
Interferons
Cytotoxic as well as helper T cells also control viral infection by virue of
sereted interferons. The clearance of non-cytopathic virses by an immune respons is
widely perceived as being mediated by the destruction of infected cells by MHC
I-restricted cytolytic T cells. However, upon antigen recognition, CTL secrete antiviral
cytokies such as IFN-
'Y or TN-a. These cytokines can severely limit viral infections
without kiling the infected cell For DNA vaccines, a non-destructive IFN-'Y-mediated
control of an infection has been reported for hepatitis B virus (HBV). Immunization of
transgenic mice that replicate the HBV genome and sustain the HBV lie cycle with a
DNA expressing the HBV surface antigen raised CD8+ cells that abolihed HBV gene
expression and viral replication while killig only a small fraction of the hepatocytes
(Mancini et al., 1996). Studies of this phenomenon using transfer of HBV surface
antigen-specific clones of CTL into the transgenic mice revealed that the antiviral effect
was mediated by IFN- 
rand TN-a (Guidotti et ai. 1996; Heise et al., 1999).
Administration of antibody to IFN- 
rand TN-a completely abolished the protective
effect, whereas administration of antibody to one, but not the other, was only partially
effective. This suggests that the liitation of virus expression was likely due to IFN- r
and TNF-a activating different but synergistic pathways for HBV control. lFaJ can
also contribute to the down regulation of HBV expression. The phenomenon can be
mediated by HBV-specifc Thl cells (Franco et al. 1997). Interestingly, these
cytokine-mediated effects have not been able to be replicated in vitro and require in vivo
experiments (Heise et al., 1999).
Antibody
DNA-raised antibody responses differ in a number of ways from those raised by
protein inoculations or viral infections. DNA-raised antibody responss rise much more
slowly than protein- or infection-raised antibody. In mice, the maximum titer that wil be
achieved by a single immunization is sometimes not reached until as late as 12 weeks
after the immunization. Titers at 12 weeks can be 5- 10 times higher than titers at 4 weeks
post immunization (Robinson et ai. 1997a). Boosts increase the rate of the ri 
responses (Robinson et al., 1997a). The appearance of antibody secreting cells (ASC) in
the bone marrow paralels the slow rise in antibody but with an approximately 4-week
delay (Boyle et al., 1996). The very slow kinetics for antibody responses following DNA
immunizations presumably reflect the raising of responses by low levels of antigen that
are expressed over several weeks. The prolonged presence of antigen serves to support
both primary and secondary phases of antibody responses. Raised antibody undergoes
avidity maturation (Boyle et ai. 1997) and ASC migrate to the bone marrow for long
term production of antibody (Boyle et ai., 1996; Slifka et ai. 1998). In murine models
the plateau titer for a DNA-expressed antigen is typically similar to that raied by the
same antigen expressed in a viral infection (Deck et ai. 1997; Michel et al., 1995;
Robinson et al. 1997a; Xiang et ai. , 1994).
DNA-raised antibody responses also differ from those raised by protein
immunizations or viral infections in that the method of DNA inoculation can be used to
bias the isotype of the raised antibody (Feltquate et ai., 1997). In mouse studies, most
protein immunizations raise C' - independent antibodies and most viral infections raise
C' -dependent antibodies. Depending on the method of delivery or the form of an antigen
DNA immunizations can be used to raise either predominantlyC' - dependent or
C'- independent an !bodies for the same protein (Figure 2 , section on T cell help).
INCREASING THE EFFICIENCY OF DNA-BASED IMMUNIZATIONS
In addition to the CpG-S sequences in plasmids that act as endogenous adjuvants
for DNA vaccines, both conventional as well as genetic adjuvants have been explored for
their abilty to increase or change the Th bias of DNA-raised immune responses.
Conventional adjuvants have included gel-type adjuvants such as alum or calcium
phosphate, bacterial adjuvants such as monophosphoryllipid A (Sasaki et ai., 1998b;
Sasaki et ai., 1997b) and cholera toxin (Ban et al., 1997; Kukli et ai., 1997), cationic
(Gregoriadis, Saffie, and de Souza, 1997; Ishii et ai., 1997) and mannan-coated
liposomes (Sasaki et ai., 1997a; Toda et al., 1997), emulsifier-based adjuvants such as
QS21 (Sasaki et ai., 1998c), and synthetic adjuvants such as carboxymethy1cellulose and
ubenimix (Sasaki et ai., 1998a). Al of these have had some effects on the effciency 
immunization.
Studies using genetic adjuvants have focused on the cotransfection of plasmids
expressing lymphokines, chemokines, or co stimulatory molecules (for review , see Cohen
Boyer, and Weiner, 1998). The vast majority of experiments have been conducted with
the native forms of lymphokines or co stimulatory molecules by codelivery of a DNA
expressing the genetic adjuvant and a DNA expressing the immunogen. Recently, a
study comparing the temporal relationship between the delivery of IL-2 or
GM-CSF-expressing DNAs and a plasmid expressing HIV- l gp120 (receptor binding
subunit of Env) revealed increases in immune responses when cytokie DNAs were
delivered after, but not at the time of the delivery of the DNA immunogen (Barouch 
at., 1998). Pre- or codelivery of the cytokie DNA resulted in amplification of
non-specifc proliferative responses and decreases in the specifc response. In contrast,
delivery at two days post immunization augmented the specific immune response that had
just ben primed. In this very thorough study, all effects were less than lO-fold, and
delivery of DNAs expressing IL- , IL-4 or GM-CSF at the same time as the delivery of
the vaccine DNA uniformly resulted in reduced (not enhanced) responses. This study
also demonstrated that when the cytokie DNA was delivered 2 days after the
immunogen, Ig-fusions of IL-2 were more effective than IL-2 alone at enhancing immune
responses. This was hypothesized to reflect a longer serum half life of the Ig fusion, the
divalent avidity of the Ig-fusions, and the abilty of the Ig-fusions to augment signaling
via initiating receptor clustering.
The reported effects of genetic adjuvants have been those that would be
anticipated (for review , see Robinson and Pertmer, 2000). Pro-inflammatory agents and
Th2 cytokies have increased antibody responses; whereas pro-inammatory agents and
Thl cytokies have increased CTL responses. Interestingly, the tested co stimulatory
agents have been more effective at inducing CTL responses than changes in Th or
antibody responses. If one further breaks down the observed phenomena to Thl or Th2
agents that have been highlighted as key inducers for the differentiation of type 1 and
type 2 responses (IFN- 
'Y and IL- 12 for Thl , IL-4 for Th2), effeCts are uniformly what
would have been anticipated. The scatterig of results on protection reveal
pro-inflammatory and Thl genetic adjuvants improving protection for viral inections
more frequently than Th2 genetic adjuvants.
In general, co inoculated genetic adjuvants have had fairly minor effects on the
magnitude of immune responses, with most increass being only two- to three-fold.
Among the best of the increases (-8-fold) occurred in a study with cotransfected CD40
ligand (Mendoza, Cantwell, and Kipps, 1997).
INFLUENZA
Influenza viruses are segmented RNA viruses that cause highly contagious acute
respiratory infections. These viruses are endemic in man, where they are particularly
devastating for the very young and the very old. The major problem associated with
vaccine development against influenza is that these viruses have the abilty to escape
immune surveilance and remain in a host population. This escape is associated with
changes in antigenic sites on the hemagglutinin (H) and neuraminidase (N) envelope
glycoproteins by phenomena termed antigenic drif and antigenic shift. Antigenic drif
occurs when a subtype of an influenza virs H (for example H3) is selected for antigenic
determinants that are not recognizd by the anti-H3 antibody present in a population.
This allows the virs to superinfect individuals who have already been infected by an H3
virs. Antigenic shif occurs when the influenza virs segmented genome reassorts to
acquire an H belonging to another subtype (for example H2 instead of H3). Thepriary
correlate for protection against influenza virs is neutralizing antibody against H protein
that undergoes strong selection for antigenic drif and shift. However, much more
conserved antigenic cross-reactivities for different strais of influenza virs occur
between internal proteins, such as the nucleoprotein (NP) (Shu, Bean, and Webster
1993). Conventional inactivated virs or protein subunit vaccines raise antibody against
H but have the limitation of being unable to generate effective CTL responses against
NP. Thus, DNA vaccines that can induce both neutralzing antibody, as well as a
NP-specifc cell-mediated immune response, offer hope for better cross-strai protection.
Early studies with DNA vaccines were done in influenza virs models (Fynan 
ai. 1993; Robinson, Hunt, and Webster, 1993; Ulmer et al., 1993). These studies
demonstrated protection in murine models following immunizations with H or
NP-expressing DNAs. Protection with the H-expressing DNA was limited to viruses of
the same subtype but was effective against highly virlent strais even following single
deliveries of DNA. By contrast, protection with NP-expressing DNA required multiple
deliveries of DNA and challenge with less virlent strais (Chen et al., 1998; Robinson 
al., 1997a; Ulmer et al. 1993). These strais, however, could be of a different subtype
than the strai from which the NP was derived (Ulmer et al., 1993). More recent studies
suggest that the codelivery of H and NP-expressing DNAs wil be more effective than
either H or NP alone (Bot, Bot, and Bona, 1998; Donnelly et al., 1995). In BALB/c
mice, the protective effect contributed by the NP DNA is mediated by both CTL and Th
(Ulmer et ai. , 1998).
DNA vaccines for influenza virs have proved effective in a number of precliical
models. However, the fIrst human trials of these vaccines, an H delivered by Lm.
immunization, had disappointing results (Clements-Mann et al., 1998).
DNA vaccines, given they can be as effective in humans as in preclinical models,
have the potential to be an important factor in limiting future influenza pandemics. A
major advantage of DNA vaccines over conventional vaccines is that they can be
developed within weeks. Vaccine DNAs can be constructed using polymerase chain
reaction techniques on infected tissue. This eliminates the time and cost it takes to
develop and produce a new virus in eggs or cell culture and eliminates the possibilty 
selection of mutant viruses in these systems.
DEFICIENCIES IN NEONATAL IMMUNE SYSTEM
Neonates have immature immune systems with deficiencies in several
components of inflammatory reactions, innate, and specifc immunity. IgG responses
often display slower kinetics and are lower in magnitude than corresponding adult
responses. Additionally, human infants are incapable of generating antibody responses to
carbohydrate determinants on bacterial capsules or to heavily glycosylated viral proteins,
the basis of which is unknown (Siegrist and Lambert, 1997). Human neonates also have
impaired monocyte/macrophage function (Johnston, 1998) that has been associated with
reduced display of MHC II and costimulatory molecules, decreased abilty to process
antigen, and altered cytokie patterns (Siegrist and Lambert, 1997). Few studies have
addressed the function of APC in neonates but it appears that in APC derived from both
human cord blood and newborn mice, maturation is slow and functionally inadequate
(Hunt et al., 1994; Lu et al., 1979), which may limit specific immunity. Similarly,
human NK cell number and function are also impaied afer birth, as assessed by IFNy
production and kiling activity. The reason for NK impairment is unclear, but may be
associated with deficient IL- 12 production by monocyteslmacrophages. Similarly,
decreased IFNy production by NK cells may contribute to the observed neonatal Th2-bias
and inabilty to generate robust cellular immune responses (Siegrist and Lambert, 1997).
Several studies have addressed the abilty to generate cellular immune responses.
Classical early studies suggested the induction of tolerance following the injection of
allogeneic cells. For example, one group showed that neonates exposed to allogeneic
hematopoietic cells did not reject subsequent skin grafts as adults (Billngham, Brent and
Medwar, 19560. These studies suggested a window of time in which lymphocyte
exposure to foreign antigens resulted in deletion. However, very little was known about
the biology of lymphocytes at the time. More recent studies showed that induction of
cellular responses in neonatal mice was dependent on antigen dose, method of
immunization, and presentation by professional APC. For instance, neonatal
immunization with either low doses of antigen, or antigen emulsified in complete
Freund' s adjuvant, elicited Thl and CTL induction; whereas high dose inoculation
resulted in a Th2-biased response (Bot, Bot and Bona, 1996; Forsthuber, Yip and
Lehman, 1996; Sarzotti, Robbins and Hoffman, 1996). H- Y-specifc CTL were
generated following transfer of adult male dendritic cell to newborn female mice, which
indicates that presentation by professional APC leads to effective priming of cellular
immune responses in neonates (Ridge, Fuchs and Matzinger, 1996). Taken together
these studies imply that low doses of antigen presented by professional APC generate
Thl and CTL induction upon immunization, whereas moderate or high doses of antigen
are associated with the generation ofTh2 cells. Thus, neonates exposed to antigens have
the tendency to develop an immunodeviated response as opposed to true immunological
tolerance (Bot, Antohi and Bona, 1997).
, ,
Neonatal mice develop preferential Th2-type responses to many vaccine antigens.
Recent in vitro studies have shown that murine neonatal T cells develop preferentially
into IL-4 and IL- 5 secreting effector cells and respond to cytokies, such as IL- , with
production of both IFNy and IL-4 (Siegrist and Lambert, 1997; Demeure et ai., 1995; Shu
et ai., 1994, Yang et ai., 1996). In vitro studies are reflected in in vivo models as well.
Neonatal mice typically develop Th2-biased responses following immunization with
inactivated and live attenuated viral vaccines, live recombinant canarypox vaccines
(Barios et ai., 1996b; Siegrist et al., 1998b) and pep tides or protein emulsifed in
Freund's complete adjuvant (Singh, Hahn, and Sercarz, 1996) or alum (Barios et al.,
1996b). This Th2 bias places neonates at a greater risk for developing severe bacterial
and viral infections, which are best controlled by Thl cell-mediated immune responses.
MA TERNAL ANTffODY INTERFERENCE WITH MANY VACCINES
The presence of high titer maternal antibody in newborns is the major form of
protection from disease in early life. Maternal IgG antibody crosses the placenta from
mother to fetus during human development (Leach et al., 1996). The titers of
transcytosed antibody in the newborn typically exceed the titer ofthe same antibody in
the mother, but can range from 20% to 200% that of the mother (Siegrist et ai., 1998c).
These levels of maternal IgG slowly decline over the ftrst year of lie, a time during
which the infant's immune system matures, becomes more experienced, and develops its
own repertoire of protective memory responses. Maternal antibody can interfere with
active immunization of the offspring (Albrecht et ai., 1977). Immunization protocols are
often delayed several months and/or require multiple booster immunizations to achieve
the desired protective immune response. This is exemplified by measles vaccination
protocols, in which barely detectable levels of maternal antibody can prevent
seroconversion following infant immunization (Albrecht et al., 1977). This observation
was the basis for recommending measles vaccination occur between 12- 15 months of age
(Siegrist et ai., 1998c). Thus, a window of time exists when maternal antibody levels are
too low to reliably protect an infant from infectious disease but high enough to prevent
vaccine responsiveness.
POTENTIAL FOR DNA VACCINES IN NEONATES
DNA vaccination is an attractive method for neonatal immunization in the
presence of maternal antibody. Maternal antibody is thought to interfere with traditional
vaccine efficacy by reducing the amount of antigen available for processing and
presentation by APe. The abilty of DNA vaccines to directly transfect cell could
bypass this problem. Additionally, the DNA vaccine itself wil not be affected by the
maternal antibody.
When this study was initiated, there were three conficting studies published
regarding DNA immunization of neonatal mice. Two of the studies, in which DNA
expressing measles N (Fooks et al., 1996) or influenza NP (Bot et ai., 1996) was
inoculated by i.m., had success in eliciting antibody responses. The third study showed
long-term tolerance following Lm. inoculation at birh with DNA expressing the P. yoell
(mouse malaria) circumsporozoite protein (Mor et ai., 1996). Due to the importance of
immunizing as soon as possible in early life, it was necessary to determine the
effectiveness of these novel DNA-based vaccines in a neonatal animal model both in the
presence and absence of maternal antibody. We wished to investigate whether tolerance
was an exception or the rule in neonatal DNA vaccination. Further, if DNA vaccination
was deemed possible, it was necessary to better characterize the associated DNA-raised
immune responses.
HYPOTHESIS
DNA vaccines are effective in generating protective humoral and cellular
immune responses in the presence or absence of maternal antibody and can
circumvent the Th2-bia normally associated with neonatl immune responses to other
vaccine preparations.
THESIS OBJECTIVES
The goal of this thesis was to characteriz the long term humoral and cellular
immune responses following neonatal DNA immunization. Although there was
substantial data in the literature regarding the effcacy of DNA vaccines in adult animal
models, relatively little was known about the longevity, and quantitative and qualitative
differences in DNA-raised immune responses of neonatal animals. A paper by Mor et aL
(1995) suggested that Lm. immunization of neonatal mice with a DNA expressing the
Plasmodium yoell (mouse malaria) circumsporozoite protein led to long term
unresponsiveness of animals to a second exposure to antigen. To determine if these
results were antigen-specific or a general rule as applied to neonatal DNA
immunizations, I set out to address the following issues:
1.) The characterization of protective humoral immune responses following neonatal
immunization with influenza hemagglutinin DNA or protein.
) Effects of codelivery of Thl cytokines on the generation of humoral and cellular
immune responses.
) The abilty to generate protective humoral responses following immunization in the
presence of maternal or passively acquired anti-influenza antibody.
) An examination of the quantitative and qualitative differences in cellular immune
responses generated following DNA vaccination in the presence or absence of anti-
influenza antibody
MATERILS AND METHODS
MATERILS AND METHODS
Cells. The murine mastocytoma cell line, p815, was purchased from American Type
Tissue Collection (# TIB 64, ATCC, Rockvile, MD).
Bacteri. Competent HB101 or DH5a. E. coli were used to amplify plasmid DNA
Virus. NPR/8/34 (HIN1) influenza virus was kindly provided by Dr. John Hermann
(University of Massachusetts Medical Center, Worcester, MA) and was grown in the
allantoic cavity of lO-day-old embryonic chicken eggs (SPAFAS, Preston, CT) at either
the University of Massachusetts Medical Center, Worcester, MA or the Centers for
Disease Control, Atlanta, GA. Virs used for coating ELISA plates was from allantoic
fluid enriched for virus by sucrose gradient centrifgation.
Mice. BALB/c mice (Taconic Farms, Germantown, NY; Harlan Sprague Dawley,
Indianapolis, IN) were housed in microisolator cages at either the University of
Massachusetts Medical Center Animal Facilty (Worcester MA) or the Emory University
Rollins or Winship Animal Facilties (Atlanta, GA). Six to eight week old female mice
were infected intranasally (in. ) with a sublethal dose of influenza NPR/8/34 and allowed
to recover from infection. Approximately 3 months later, these influenza-immune mice,
as well as naive females, were bred. Pregnant females were separated into individual
cages and monitored daiy for birhs. Birth dates were recorded as the dates the litters
were discovered. Pups were weaned and sex separated at 3-4 weeks of age. Age at the
time of immunization is as noted in the various chapters.
Plasmid DNA. pJW4303/HA (HA DNA) and pCMV/NP (NP DNA) plasmid vector
construction and purifcation procedures have been previously described (Feltquate 
ai., 1997; Pertmer et ai., 1995). The pIL- 12 vector is pWRG 3169 mIL12 and is a
bicistronic plasmid containing the seuences for p35 subunit, an internal ribosomal entry
site, and the p40 subunit. The pIFNy is pWRG 3154 pCMV/mIFN-M gamma. Both
cytokine vectors were kidly provided by Deb Fuller (Powderject Vaccines, Inc.
Madison, WI). Al vectors are under the transcriptional control of the cytomegalovirs
immediate-early promoter. The empty pJW4303 vector was used as a negative control
Plamids were grown in either DH5a or HB101 E. coli and purifed using Qiagen
(Chatsworth, CA) UltraPure- l00 columns. All plasmids were verifed by appropriate
restriction enzyme digestion and agarose gel electrophoresis. Purity of DNA preparations
was determined by optical density readings at 260 and 280 nm. All plasmids were
resuspended in TE buffer and stored at - C until use.
Pepties. The K -restricted HA533-541 peptide (IYSTV ASSL) (Winter, Fields, and
Brownlee, 1981) or the K -restricted NP 147 155 peptide (TYQRTRAV) (Rotzschke 
al. 1990) were used for CTL lysis assays and CTL FACS analysis. Both pep tides were
synthesized at Emory University (Atlanta, GA).
Subunit vaccine. An influenza NPRl8/34 (HIN1) subunit vaccine preparation was used
as described (Feltquate et al., 1997). Briefly, the surface HA and neuraminidase (NA)
antigens from influenza virus particles were extracted using a nonionic detergent (7.
N-octyl- thioglucopyranoside). Afer centrifugation, the HAIA-rich supernatant
55% HA) was used as the subunit vaccine. Doses of 10, 1 , or O. g were delivered in a
volume of 0.4 ml of sterile 0.9% salie.
Preparation of DNA-coated gold beads for g. g immunizations. Plasmid DNA was
precipitated onto the appropriate amount of m gold beads (BioRad, Hercules, CA).
One hundred microliters of 50 ro spermidine was added to the appropriate volume of
plasmid DNA and sonicated briefly. Two hundred microliters of 1 M CaCh was then
added dropwise while vortexing. DNA was allowed to precipitate onto the gold beads for
5 minutes. The beads were pelleted and washed 3 times with 100% EtOH and
resuspended in 100% EtOH to a fmal concentration of 7 mg DNA-coated gold beads per
1 ml of EtOH (Robinson and Pertmer, 1998). In situations where more than one vaccine
DNA was codelivered , separate DNA-coated gold bead preparations were made and then
mixed to a fmal concentration of 7 mg gold/ml EtOH; whereas when genetic adjuvants
were codelivered, DNAs were mixed and gold beads contained both DNAs (Robinson
and Pertmer, 1998).
Preparation of DNA/gold-coated cartriges for g. g. immunizations. To prepare the
cartridges for g.g. immunization, the DNA-coated gold beads must be spread evenly
around the inside ofteflon tubing. The DNNgoid suspension was drawn into teflon
tubing 1/8 inch in diameter. (McMaster-Carr, Chicago, IL) using a 10 cc syringe fitted
with a tubing adapter. The tube was then quickly slid into a ' 'tube turner" (Powderject
Vaccines, Inc., Madison, WI) and allowed to settle for 5 minutes. The EtOH was drawn
off at a rate of - 1 in.lsec. using the syringe, and the tube was allowed to rotate at 20 rpm
for 30 sec. to evenly coat the DNA-coated gold beads around the interior of the tubing.
The tube was then dried by allowing nitrogen gas to flow through the tube at a rate of
0.4 Umin. while continuously rotating. The tube was removed and cut into 1 inch.
lengths using a cutting device (Powderject Vaccines, Inc. , Madison, WI). Each carridge
contaied Illg of total DNA per 0.5 mg of gold unless otherwise noted. The carridges
were stored in paraffm-sealed vials containing desiccant pellets at 4 C unti use
(Robinson and Pertmer, 1998).
Gene gun DNA immunizations. Six- or 12-week-old young adult mice were
anesthetizd with 0.03- 04 ml of a mixture of 5 m1 ketamine HCl (100 mglml) and 1 
xylazine (20 mglml). Gene gun immunizations were performed on abdominal skin using
the hand-held AccellQi gene delivery system (Powderject Vaccines, Inc., Madison, WI) as
described previously (Pertmer et al., 1995). Adult mice were anesthetized and
abdominal skin was shaved with electric clippers. Neonatal mice were neither
anesthetizd nor shaved. Both groups of mice were immunized with a single gene gun
dose contaiing a total of Illg of DNA per 0.5 mg 111m gold beads (BioRad, Hercules,
CA) at a helium pressure setting of 400 psi (Robinson and Pertmer, 1998).
Intramuscular immunizations. Six- or 12-week-old young adult mice were anesthetized
with 0.03- 04 ml of a mixture of 5 ml ketamine HCI (100 mg/ml) and 1 ml xylazine (20
mg/ml). Intramuscular DNA immunizations involved injection of 0.04 ml of sterile 0.
salie containing 50 Ilg total DNA into a surgically exposed quadriceps muscle (Pertmer
Roberts, and Haynes, 1996). One-day-old unanesthetizd neonatal mice were injected
with an equivalent DNNsalie injection into the gluteus maximus muscle. Surgical
exposures were not performed in the neonatal animals (Robinson and Pertmer, 1998).
Influenza A/PRlSI34 virus challenge. Metofane-anesthetizd mice were challenged by
intranasal inoculation of 50 III of influenza NPR/8/34 (HIN1) virs containing allantoic
fluid diluted 10-4 in PBSI2% BSA (50- 100 LDso; 0.25 HAU). Mice were weighed daily
and sacrifced following )-20% loss of pre-challenge weight. At this dose of challenge
virs, 100% of naIve mice succumbed to influenza infection by 4-6 days. Sublethal
infections were done similarly using a 10- dilution of virs.
Detection of serum IgG by enzyme-linked immunosorbant assay (ELISA). At various
times pre- and/or post-immunization, mice from each group were bled, and individual
mouse serum was assayed by standard quantitative ELISAs to assess anti-HNN-
specifc IgG, IgG 1 , IgG2a, IgG2b, IgG3, IgA or IgM levels in immune serum. Sera were
collected individually and stored at - C until use. Sucrose gradient-purified NPR/8/34
influenza virus was disrupted in flu lysis buffer (0.05 M Tris-HCL (pH 7. 8),
TritonX- 100, 0.6 M KCl) for 5 minutes at room temperature. Ninety-six well ELISA
plates (Corning, Cornig, NY) were coated with 200 HAU flu in carbonate buffer (0.8 g
C03, 1.47 g NaHC0 , 500 ml ddHzO, pH to 9.6) and incubated overnight 4 e. Plates
were blocked with 200 III of 1 % BSA in PBS for 1 hour at 37 C and washed 5 times with
PBS/0. 025% Tween-20. Samples and standards were diluted in SDB (0.5% BSA in
PBS), added to microtiter plates at 50 III per well, and incubated at 37 C for 90 min.
Following binding of antibody, plates were washed 5 times. Fifty microliters of HRP-
labeled goat anti-mouse Ig subtype antibody (Southern Biotechnology Associates) was
then added at optimized concentrations in SDB , and plates were incubated for 1 hour at
C. Afer washing plates 5 times, 100 III of ABTS substrate (10 ml 0.05 M Citrate (pH
0), 5 u130% Oz, 50 u140 ro ABTS) was added. Color was alowed to develop 
room temperature for 30 min., and the reaction was stopped by adding 10 III of 10% SDS.
Plates were read at O. 4os. Data were analyzed using Softmax Pro Version 2.
computer software (Molecular Devices, Sunnyvale, CA). Data are shown as geometric
mean titers (GMT) unless otherwise indicated.
Preparatin and stimulation of splenocytes for cytokine production. Spleens were
harvested from groups of immunized mice (n=2-3) and pooled in p60 petri dishes
contaiing -4ml RPMI- lO media (RPMI- 1640, 10% fetal bovine serum, 50 Ilglml
gentamycin). Al steps in splenocyte preparations and stimulations were done
aseptically. Spleens were minced with curved scissors into fme pieces and then drawn
through a 5 cc syringe attached to an 18G needle several times to thoroughly resuspend
cells. Then cells were expelled through a nylon mesh strainer into a 50 ml polypropylene
tube. Cells were washed with RPMI- lO, red blood cells were lysed with ACK lysis
buffer (Sigma, St. Louis, MO), and washed 3 more times with RPMI- lO. Cells were then
counted by trypan blue exclusion, and resuspended in RPMI- I0 containing 80 U/ml rat
IL-2 (Sigma, St. Louis, MO) to a fmal cell concentration of 2x10 cellslml. Cells to be
used for intracellular cytokie staining were stimulated in 96-well flat-bottom plates
(Becton Dickenson Labware, Lincoln Park, NJ), and cells to be used for cytokie analysis
of bulk culture supernatants were stimulated in 96-well U-bottom plates (Becton
Dickenson Labware, Lincoln Park, NJ). One hundred microliters of cells were dispensed
into wells of a 96-well tissue culture plate for a fmal concentration of 2x10 cells/welL
Stimulations were conducted by adding 100 III of the appropriate peptide or inactivated
influenza virus diluted in RPMI- I0. CD8+ T cell were stimulated with either the K
restricted HAs S41 peptide (IYSTV ASSL) (Winter, Fields, and Brownlee, 1981) orthe
-restricted NP 47-1SS peptide (TYQRTRAV) (Rotzschke et al., 1990). CD4+ T cells
were stimulated with inactivated influenza virs (13,000 HAU per well of boiled
influenza virs plus 13,000 HAU per well of formalin-inactivated influenza virs) plus
anti-CD28 (1Ilglml) and anti-CD49d (lllglml) (Waldrop et al., 1998). Negative control
stimulations were done with media alone. Cells were then incubated as described below
to detect extracellular cytokies by ELISA or intracellular cytokies by F ACS staining.
Chromium release assay for CTL. CTL responses to influenza HA and NP were
measured as previously described (Fuller and Haynes, 1994), except the synthetic peptide
HA533-541 IYSTV ASSL (Winter, Fields, and Brownlee, 1981) or NP 147 155
TYQRTRALV (Rotzschke et al., 1990) was substituted for the human
immunodeficiency virus type 1 gp120 peptide in the target preparation step. Responder
splenocytes from each animal were washed with RPMI- I0 and resuspended to a fmal
concentration of 6.3x10 cells/ml in RPMI- lO containng 10 U/ml rat IL-2 (Sigma, St.
Louis, MO). Stimulator splenocytes were prepared from naIve, syngeneic mice and
suspended in RPMI- lO at a concentration of lx10 cellslml. Mitomycin C was added to a
fmal concentration of 25 Ilg/ml. Cells were incubated at C15%C0 for 30 minutes and
then washed 3 times with RPMI- lO. The stimulator cells were then resuspended to a
concentration of2.4x10 cells/ml and pulsed with HA peptide at a fmal concentration of
9xlO M or with NP peptide at a fmal concentration of 2xlO M in RPMI- lO and 10 U/ml
IL-2 for 2 hours at C15% . The peptide-pulsed stimulator cell (2.4x10 ) and
responder cells (6.3x10 ) were then co incubated in 24-well plates in a volume of2 ml SM
media (RPMI- , 1 ro non-essential amino acids, 1 mM sodium pyrvate) for 5 days at
C/5%C0 . A chromium-release assay was used to measure the abilty of the in vitro
stimulated responders (now called effectors) to lyse peptide-pulsed mouse mastocytoma
p815 cells. P815 cell were labeled with Cr by taking 0. 1 ml aliquots ofp815 in RPMI-
10 and adding 25 III FBS and 0. 1 mCi radio labeled sodium chromate (NEN, Boston, MA)
in 0. 2 ml normal saline. Target cells were incubated for 2 hours at C/5%C0 washed
3 times with RPMI- lO and resuspended in 15 ml polypropylene tubes containing RPMI-
10 plus HA (9xlO- M) or NP (lxlO- ) peptide. Targets were incubated for 2 hours at
CI5%C0 The radiolabeled, peptide-pulsed targets were added to individual wells of
a 96-well plate at 5x104 cells per well in RPMI- lO. Stimulated responder cells from
individual immunization groups (now effector cells) were collected, washed 3 times with
RPMI- lO, and added to individual wells of the 96-well plate containing the target cells
for a fmal volume of 0.2 mVwel1. Effector to target ratios were 50: 1 , 25: 1 , 12.5: 1 and
25: 1. Cells were incubated for 5 hours at 37 C15%C0 and cell lysis was measured by
liquid scintilation counting of 25 l aliquots of supernatants. Percent specifc lysis of
labeled target cells for a given effector cell sample was 100x(Cr release in sample-
spontaneous release sample) (maximum Cr release-spontaneous release sample).
Spontaneous chromium release is the amount of radioactive released from targets without
the addition of effector cells. Maximum chromium release is the amount of radioactivity
released following lysis of target cells after the addition of TritonX- lOO to a fmal
concentration of 1 
%. 
Spontaneous release was 13% of the maximum release.
Detection of IFNyor IL-S in bulk culture supernatants by ELISA. Pooled splenocytes
were incubated for 2 days at 37 C in a humidifed atmosphere containing 5% C02.
Supernatants were harested, pooled and stored at - C until assayed by ELISA All
ELISA antibodies and purifed cytokies were purchased from Pharmingen (San Diego,
CA). Fify microliters of purified anti-cytokine monoclonal antibody diluted to 5 glml
(rat anti-mouse IFNy) or 3 glml (rat anti-mouse IL-5) in coating buffer (0. 1 M NaHC0
pH 8.2) was distributed per well of a 96-well ELISA plate (Corning, Corning, NY) and
incubated overnight at 4 e. Plates were washed 6 times with PBS/0. 025% Tween-
(PBS- T) and blocked with 250 1 of 2% dry milkBS for 90 min. at 37 C. Plates were
washed 6 times with PBS-T. Standards (recombinant mouse cytokie) and samples were
added to wells at various dilutions in RPMI- I0 and incubated overnight at 4 C for
maximum sensitivity. Plates were washed 6 times with PBS- T. Biotinylated rat anti-
mouse cytokine detecting antibody was diluted in PBS- T to a fmal concentration of 2
Ilg/ml and 100 III was distributed per well. Plates were incubated for 1 hr. at 37 C and
then washed 6 times with PBS-T. Streptavidin-AP (Gibco BRL, Grand Island, NY) was
diluted 1:2000 according to manufacturer s instructions, and 100 III was distributed per
well. Plates were incubated for 30 min. and washed an additional 6 times with PBS- 
Plates were developed by adding 100 IlVwell of AP developing solution (BioRad
Hercules, CA) and incubating at room temperature for 50 minutes. Reactions were
stopped by addition of 100 III OAM NaOH and read at OD40s. Data were analyzed using
Softmax Pro Version 2.21 computer software (Molecular Devices, Sunnyvale, CA).
Intracellular cytokine staining and F ACS analysis. Pooled splenocytes were incubated
for 5-6 hours at 37 C in a humidified atmosphere containing 5% CO . A Golgi tranport
inhibitor, Monerisin (Pharmingen, San Diego, CA), was added at 0. 14 IlVwell according
to the manufacturer s instructions, and the cells were incubated for an additional 5-
hours (Waldrop et ai., 1998). Cells were thoroughly resuspended and tranferred to a 96-
well U-bottom plate. All reagents (GolgiStop kit and antibodies) were purchased from
Pharmingen (San Diego, CA) unless otherwise noted, and all FACS staiing steps were
done on ice with ice-cold reagents. Plates were washed 2 times with FACS buffer (Ix
PBS, 2% BSA, 0. 1 % w/v sodium azide). Cells were surface stained with 50 III of a
solution of 1:100 dilutions ofrat anti-mouse CD8j3-APC, -CD69- , and CDI6/CD32
(FcyIIIIRII; 'Fc Block' ) in FACS buffer. For tetramer staining, cells were similarly
stained with CD8j3-TriColor, CD69- CDI6/CD32 and HA- or NP-tetramer-APC in
F ACS buffer. Cells were incubated in the dark for 30 min. and washed 3 times with
F ACS buffer. Cells were permeabilzed by thoroughly resuspending in 100 J.l of
CytofIxJCytoperm solution per well and incubating in the dark for 20 minutes. Cells
were washed 3 times with Permwash solution. Intracellular staing was completed by
incubating 50 J.l per well of a 1: 100 dilution of rat anti-mouse IFNy-FIC in Permwash
solution in the dark for 30 min. Cells were washed 2 times with Permwash solution and
1 time with FACS buffer. Cells were fIxed in 200 J.l of 1 % paraformaldehyde solution
and transferred to micro tubes aranged in a 96-well format. Tubes were wrapped in foil
and stored at 4 C until analysis (less than 2 days). Samples were analyzed on a
FACScanC! flow cytometer (Becton Dickenson, San Jose, CA). Compensations were
done using single-stained control cells stained with rat anti-mouse CD8-FITC, -
, -
TriColor, or -APe. Results were analyzed using FlowJo Version 2.7 software (Tree Star,
San Carlos, CA).
Tetramers. Tetramers were prepared essentially as described previously (Flyn et ai.,
1998). The present experiments utilzed the H- MHC class I glycoprotein complexed
the synthetic influenza NPR/8/34 virs peptide HAS33-S41 (IYSTV ASSL) (Winter
Fields, and Brownlee, 1981) or NP14-1SS (TYQRTRAV) (Rotzschke et ai., 1990).
The K vector was kidly provided by John D. Altman (Emory University Vaccine
Research Center, Atlanta, GA).
Statitical Analysis. Student's test was calculated using Sigma Plot for Windows
version 1.02 (Jandel Scientific, San Rafael, CA) or Microsoft Excel 97 SR- l (Microsoft
Corporation, Seattle, W A). Means and standard deviations were calculated using
Microsoft Excel 97 SR- l (Microsoft Corporation, Seattle, W A). Fisher Exact Test and
ANOV A analyses of variance were kindly performed by Dr. James Herndon at Emory
University (Atlanta, GA). Probabilties greater that = 0.05 were considered
insignificant.
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HYPOTHESIS
DNA vaccines are effective in eliciting protective IgG responses in neonatal
mice and can circumvent the Th2-bias normally associated with neonatal immune
responses to other vaccine preparations.
INTRODUCTION
Neonates have an immature immune system with deficiencies in several
components of inflammatory reactions, and innate and specific immunity (Hunt et ai.
1994; Schelonka and Infante, 1998; Trivedi et ai., 1997). This immaturity is reflected in
a Th2 bias in murine immune responses to several vaccine preparations. These vaccines
include inactivated and live attenuated viral vaccines, live recombinant canarypox
vaccines (Barrios et ai. 1996a; Siegrist et al. 1998b), and peptides or proteins
emulsified in Freund' s complete adjuvant (Singh, Hahn, and Sercarz, 1996) or alum
(Barios et ai., 1996b). In mice, Th2 patterns of immune responses are characterized by
a preferential production of complement-independent IgGI antibodies with low
production of complement-dependent IgG2a antibodies, whereas Thl responses are
characterizd by production of IgG2a and not IgG 1 antibody. Consistent with these
1 The data presented in this chapter have been published by Pertmer and Robinson
, 1999.
isotype profies, antigen-specific CD4+ Th2-type T helper cells produce IL- , which
supports switching to IgG 1 and IgE, while Thl-type T helper cells are characterized by
the generation of IFNy which supports switching to IgG2a. Th2-type responses also have
different patterns of CD8+ CTL activity (Mosmann et al., 1995; Mosmann et ai., 1997).
The Th2 bias of the infant immune system places neonates at a greater risk for
developing severe bacterial and viral infections , which are best controlled by Thl cell-
mediated responses.
It has been well documented that immunization of adult anmals with antigen-
expressing plasmid DNAs raise strong, long- lasting, protective antibody and CTL
responss (for reviews , see Donnelly et al., 1997; Robinson and Torres, 1997; Robinon
and Pertmer, 2000). DNA vaccines have the advantage of allowing protein production to
occur within cells and thereby permits presentation of peptidesin the context of both
MHC class I and class II molecules. For many antigens, the Th bias of DNA-raised
responses seems to be dependent on the method of DNA inoculation. For instance, im.
inoculation with influenza NPR/8/34 nuc1eoprotein- or hemagglutinin (HA)- expressing
DNA in saline produces a strong Thl bias; whereas g.g. DNA delivery produces a strong
Th2 bias (Feltquate et ai., 1997; Pertmer, Roberts, and Haynes, 1996). In addition, both
methods of DNA inoculation induce strong cytolytic T cell activity (Pertmer, Roberts,
and Haynes, 1996). It was therefore of interest to evaluate the effcacy of DNA
immunization of newborns and determine the capacity of DNA vaccines to overcome the
Th2 bias characteristic of neonatal immune responses.
All but one study utilizing i.m. inoculation of DNAs in young mice have raised
humoral and cell-mediated immune responses (Bot et ai. 1996; Butts et al., 1998; Fooks
et ai., 1996; Hassett, Zhang, and Whitton, 1997; Sarzotti et ai., 1997; (Siegrist et ai.
1998b; Siegrist and Lambert, 1997; for exception see Mor et ai. 1996. Two groups
(Marinez et ai., 1997; Wang et ai., 1997) showed similar IgG subtypes elicited in adult
and newborn DNA-primed animals. In contrast, two other groups (Bot et ai. , 1997;
Manickan, Yu, and Rouse, 1997) showed differences in the predominant IgG subtypes
between adults and neonates, with adults generating mainly a Thl profIe and pups
generating a mixed Thl/Th2 profIe.
In this chapter, we compare Lm. and g.g. HA DNA vaccination of one-day-old
and young adult BALB/c mice. HA DNA-vaccinated mice were also compared with
groups vaccinated with various doses of an NPR/8/34 virs subunit vaccine in saline.
Antibody isotyping was performed as an indirect measure ofThl- or Th2-type biased
responses (Feltquate et al., 1997). Patterns of humoral responses also were evaluated
following a secondary immunization later in life to determine whether Th-types had been
fIxed by the primary neonatal immunization and whether tolerance or anergy had
occurred in non-responders.
RESULTS
Immunization of I-day-old neonates with HA DNA, but not HAprotein, induces a
strong IgG response.
Mice immunized at one day of age with HA DNA, but not HA protein, generated
anti-HA IgG responses similar in titer to mice immunized as adults (Figures 4 and 5).
Mice were given a primary immunization at 1 day or 6 weeks of age. Intramuscular and
gene gun HA DNA inoculations delivered 50 Ilg and Illg ofHA DNA, respectively,
whereas more conventional protein immunizations delivered 10, 1 , or O. lllg of an
influenza NPR/8/34 subunit vaccine in saline. Serum samples were collected 4, 10 and
22 weeks later for assessment of titer and longevity of anti- HA-specific IgG responses.
HA DNA-raised antibody responses were similar in mice immunizd as adults or
neonates (Figure 4). Four weeks following the primary immunization, most ofthe mice
had low to undetectable IgG responses (data not shown). These responses substantially
increased by 10 weeks post-prie in both the neonatal and adult immunizd groups
revealing overall similar kinetics of the IgG responses. At 22 weeks post-prie, the IgG
responses remained stable (Figure 4). The mean post-prime IgG titer of mice HA DNA-
immunized as newborns by i.m. inoculation was 24. 1 :t 19.5 Ilglml (n=l1) and by g.
delivery was 16. 1:t 25.71lglml (n=l1). Some ofthe mice HA DNA-primed at birh
developed very low to undetectable levels of IgG (3/11 Lm. and 4/11 ). The mean
post-prime IgG titer in adult HA DNA-vaccinated mice was 17. 8:t 1O.51lglml (n=4) and
17.9:t 5. Ilg/ml (n=6) for Lm. and g.g. inoculated mice, respectively. Differences in
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Figure 4. Anti-HA-specific IgG responses after Lm. or g.g. HA DNA immunization of 6-week-
or l-day-old mice. Mice were immunized with (A) 50 J.g ofHA DNA dissolved in salne by Lm.
inoculation or (B) 1 J.g HA DNA by g.g. delivery. Primary immunizations were given to mice at
either 6 weeks or 1 day of age. A second equivalent booster immuniation was given 22 weeks
later. Serm samples were collected at 10 and 22 weeks post-prime and 5 weeks post-boost and
assayed for anti-HA-specific IgG by ELISA. Data are for individual mice.
1000
;; 100
!. 10 
. 10 wk. post-prime
S! 22 wk. post-prime
13 3 wk. post-bost
. ; 
6 weks 1 day
Ag at time 01 prim Inmnlzlon
;: 
m..............mm........mmmm mmmmm mmm m.m
!. 10
 ..
..11...1L...o6 weks 1 day
Ag at time 01 pr 1tmlZon
...
_mmmmmmmm_mmmm mmmm mmmmmmmm mmm
;; 100
!. 10
6_1t 1 da
Ag at time of pr Irmtlon
Figure 5. Anti-influenza-specifc IgG responses after immunization of 6-week- or 1-
day-old mice with various amounts of an NPR/8/34 virs subunit vaccine. Mice were
Lm. immunized with (A) 10 g, (B) 1 g, or (C) 0. g of an NPR/8/34 virus protein
subunit vaccine preparation in 40 l of saline. Priary immunizations were given at
either 6 weeks or 1 day of age. A second equivalent booster immunization was given 22
weeks later. Serum samples were collected at 4 and 10 weeks post-prime and 3 weeks
post.,boost. Serum was assayed for anti-influenza-specifc IgG Ab responses by ELISA.
Data are for individual mice.
IgG titers between mice primed with HA DNA as newborns or adults were not
statistically significant (Lm. p=0.57, g.g. p=0.86). Mice immunized with the pJW4303
vector DNA contaiing no insert had undetectable anti-HA-specifc IgG levels (data not
shown).
In contrast to the DNA immunizations, neonatal mice immunized with an
influenza protein subunit vaccine had no detectable IgG responses (Figure 5). Adult mice
immunized with 10 and g of the virus subunit vaccine generated high levels of anti-
influenza-specific IgG, with 10 g eliciting stronger IgG responses (64.6:! 24. glml
n=5) than 1 g (18.7:! 13. glml, n=5). These responses persisted for greater than 22
weeks. The 0. g dose did not generate IgG responses in mice primed either as adults or
newborn.
Secondary HA DNA or protein immunizations given 22 weeks after priming
caused an increase in anti-HA-specific IgG levels in all animals (Figures 4 and 5). 
mice that had responded to the HA DNA as neonates had boosts in IgG titers (Figure 4).
The magnitude of these boosts did not differ from that in adult-primed animals (Lm.
p=O.4, g.g. p=0.7). The non-responding mice HA DNA primed as neonates generated
low but detectable anti-HA-specific IgG responses 5 weeks following the second HA
DNA immunization indicating tolerization had not occurred. These low responses were
comparable to those attaied in mice at 4 weeks post-prie (data not shown). Al ofthe
previousW non-responding mice that were primed as neonates with 10 or 1 g of viral
subunit developed post-boost mean titers of anti- inuenza IgG that were comparable to
responses generated in adults following the primary immunization (p=0.32 and p=0.
respectively). Both non-responders primed as adults (6/6) or neonates (517) with 0. 1 Jlg
of subunit vaccine also generated low but detectable anti-influenza IgG responses after
the booster immunization (Figure 5). The post-boost mean anti-influenza IgG titer for
mice primed as adults was 20.2:t 16.6 Jlg/ml (n=6) and primed as newborns was 5.7 :t
8 Jlg/ml (n=7). The differences in titers between the two groups was signifcant
(p-=0.03). This may reflect low-level priming in the adults following the fIrst
immunization.
Neonatal HA DNA immunization elicits a mixed Th profile; whereas protein elicits a
Th2-biased profile
Mice HA DNA- immunized as neonates lacked the strong polarization of IgG
prof1es observed in mice immunized as adults with DNA or protein (Table 1). Sera from
mice Lm. or g.g. HA DNA- immunized or protein immunized as pups or adults was
further analyzed for anti-HA-IgG2a and -IgGI prof1es. These isotype profies have ben
shown to correlate well with Thl and Th2 cytokie prof1es (Feltquate et ai., 1997).
Mice HA DNA immunized as adults generated polarized IgG profies that were
dependent on the method of inoculation, whereas mice immunized as pups did not
(p-=O.OOI; Table 1). As expected, at 22 weeks post-prime adult mice im. DNA-
immunized generated a strong IgG2a (3/4) response and g.g. DNA-immunized generated
a strong IgGI (6/6) onse. The strong isotype polarization seen in mice HA DNA-
Table 1. Isotype profies of mice immunized at 6 weeks or 1 day of age by i.m. or g.
inoculation of HA-DNA or i. m. with various amounts of an NPR/8/34 virus subunit
vaccine in saline.
Isot rofie
e at time of Assa time
Intramuscula DNA 6 weeks 22 wk. PP 1/4 3/4
5 wk. PB 4/4
1 day 22 wk. PP 5/9 2/9 2/9
5 wk. PB 1/9 6/9 2/9
Gene gun DNA 6 weeks 22 wk. PP 5/6 1/6
5 wk. PB 5/6 1/6
1 day 22 wk. PP 1/7 3/7 3/7
5 wk. PB 3/9 1/9 5/9
Protein - 10 6 weeks 22 wk. PP 5/5
3 wk. PB 5/5
1 day 22 wk. PP
3 wk. PB 5/8 3/8
Protein - 1 6 weeks 22 wk. PP 5/5
3 wk. PB 5/5
1 day 22 wk. PP
3 wk. PB 7/7
Protein - 0. 6 weeks 22 wk. PP
3 wk. PB 5/6 1/6
1 day 22 wk. PP
3 wk. PB 1/1
Mice were imunize and serum was collected as given in Figurs 4 and 5. Serum was assayed for anti-HI-specific
IgGl and IgG2a Ab by EUSA. IgA, IgM, IgG2b and IgG3leveis were below the level of detection (dat not
shown). Data ar shown as number of anals with a specific predominant isoty over tota number of anals
observed. IgGI, an IgGI to IgG2a ratio of ::2; Mi, an IgGI to IgG2a rato of 0.5-2; IgG2a, an IgGI to IgG2a ratio
of..0.
pp, post-prie; PB, post-boost.
.., below detection.
These dat poled with independent data from simlar groups in Tables 2 and 3, showed that differences in IgG
isoty patterns between one-day-old and young adult imunizations following both i.m. and g.g. were significant
(Fisher Exact Test, alternative hypothesis, two-sided, p-:O.OOI).
primed as adults was in contrast to mice that were DNA-primed within 1 day of birh.
Mice receiving a primary HA DNA immunization at birth had no apparent pattern ofTh-
bias regardless of the method used. At 22 weeks post- prime, 5/9 mice that responded to
the neonatal Lm. HA DNA immunization had an IgGI predominance, 2/9 had a mixed
(1: 1) IgG 1 :IgG2a response, and 2/9 had an IgG2a bias. It could be argued that the lack of
strong IgG2a predominant responses in these mice is due to the Th2-bias of neonatal
mice. However, at 22weeks post-prime, mice HA DNA immunized as newborns using
the gene gun also failed to show an isotype bias. In the groups of responding mice, 1/7
had an IgGI predominance, 3/7 had a mixed response, and 3/7 had an IgG2a
predominance. These data were surpriing due to the strong Th2 bias in adult immune
responss raised by gene gun DNA inoculations (Feltquate et ai. 1997; Pertmer
Roberts, and Haynes, 1996; Robinson and Torres, 1997). Isotype profies establihed 
both neonates and adults were maintained at boost in agreement with previous studies
showing Th cell bias is maintained once Thl or Th2 fate has been determined (Barios
et al., 1996b; Barios et ai. 1996a; Feltquate et ai., 1997; Pertmer, Roberts, and Haynes,
1996).
Al adult mice that received either 10 or 1 g of an NPR/8/34 protein subunit
vaccination generated the expected IgG 1 antibody isotype predominance, which
remained stable following a boost (Table 1). Although mice primed as neonates did not
generate a detectable primary antibody response, a boost given at 22 weeks of age
generated an IgGI predominance. Most (5/8) of the neonates that received 10 g of the
f'-
viral protein subunit vaccine had an IgG I-predominance, whereas a mixed IgG l/IgG2a
response was seen in the remaining mice (3/8). In the group that received a 1 g protein
booster immunization, an expected IgG 1 predominance was observed in all mice (n=5).
The difference in the appearance oflgG2a in the 10 g versus the 1 g group may reflect
previous fmdings in which high doses of soluble protein elicit Thl-type responses
whereas low doses generate Th2-type responses in neonates (Constant and Bottomly,
1997).
IgG profile polarizatin following HA DNA immunization and efficacy of protein
subunit vaccination is determined by age.
Age at the time of vaccination determined both the pattern of IgG proftes
following HA DNA immunization and the effectiveness of protein immunization. To
examine the effect of age on the generation of polaized IgG2a and IgG 1 responses
following i.m. and g.g. DNA inoculation or on the responsiveness of young mice to the
protein subunit vaccine, groups of mice were immunized by Lm. or g.g. HA DNA
inoculation or with 10 , 1, or 0. g of protein subunit in saline at 1 , 7, or 14 days of age.
Serum samples were collected 4-6 weeks post-prie and assayed for specifc IgG, IgGl
and IgG2a by ELISA.
Polaized patterns of IgG responses appeared by 2 weeks of age (Table 2). 
seen previously (Table 1), mice im. or g.g. DNA-immunized at birh generated a variety
ofresponses, with some havin predominantly IgGl, some having predominantly IgG2a,
Table 2. Isotype profies of mice immunized at various ages by i.m. or g.g. inoculation
ofHA-DNA.
Isotype profie
Method of DNA
inoculation
Intramuscular
Age at time of primary
immunization
6 weeks
Mix
1/9
G2a
8/9
14 days 515
7 days 1/5 4/5
1 day 6/10 4/10
1 day
12/12
616
5/9 3/9 1/9
3/9 2/9 4/9
Gene gun 6 weeks
14 days
7 days
Mice of various ages were imunize as given in Figure 4, and serum was collected at 4-6 weeks post-
prie. Serum was assayed for anti-HI-speific IgGI and IgG2a Ab by ELISA. Isotype profies were
determed by comparg IgG I : IgG2a ratios of mice with detectable IgG. The number of individual
mice which scored IgGI (ratio ::2), IgG2a (ratio -:0.5), or Mix (ratio between 0.5 and 2) are shown as a
fraction of the tota teste. Results are combined data from two independent experiments.
These data pooled with independent data from similar groups in Tables I and 3 showed that differences 
IgG isotype patterns between one-day-old and young adult imunizations following both i.m. and g.
were significat (Fisher Exact Test, alterative hypthesis, two-sided, p-:O.OOI).
and some having approximately equal mixtures of IgG 1 and IgG2a isotypes. However
mice immunized at 2 weeks of age had the expected polarization of responses with 6/6 
g. immunized mice developing IgG I-biased responses and 515 m. immunized mice
developing IgG2a-biased responses.
A similar age dependence was observed for the abilty to immunize with 10 or 1
/lg of protein subunit (Figure 6). As expected, mice immunized at birh did not develop
an IgG response following immunization with 10 or 1 /lg of protein confIrming previous
data (Figure 5). Immunizations performed at 14 days of age with either of the two doses
produced low anti- influenza IgG in 7/10 (10 /lg) and 5110 (1 /lg) mice. All six-week-old
adult mice immunized with protein subunit generated strong anti-influenza IgG responses
4 weeks post-prie, with 10 /lg eliciting better responses (28.0:t 11.9 /lglml; n=6) than 1
/lg (9. 1 :t 6.0 /lglml; n=5).
Mice HA DNA immunized at birth are protected from AIPR/8/34 challenge
Anti-HA-specific IgG responses generated by a single neonatal Lm. or g.g. HA
DNA inoculation afforded long-term protection from influenza NPR/8/34 virus
challenge (Figure 7). One-day- and 8- week-old mice were im. (25 /lg) or g. g. (1 /lg) 
DNA-immunized to compare the long-term protective effcacy of a single immunization.
Eight to nine months later, mice were assayed for anti-HA-IgG responses and challenged
intranasally (in. ) with a lethal dose of influenza NPR/8/34. All mice Lm. or g.
:; 10
:E 10
100
ilil
::::.~~~
:111:
.. ...
Iii.
:.:.; : :::: ::::
II:
III
~~~ ~~~~ ::::~~~~ ~
!I!
..... .. ... 
6 weeks 14 days 7 days
Age at time of immunization
1 day
100
':-:':.:-:':":':'
1111!:::1 
::::::
nUi
6 weeks 14 days 7 days
Age at time of immunization
1 day
Figure 6. Anti-influenza-specifc IgG responses after immunization of 1- , 7- , 14-day- or
6-week-old mice with 10 or l/lg of an NPRl8/34 virs subunit vaccine. Mice were i.
immunized with either (A) 10 /lg or (B) l/lg of an NPR/8/34 virs protein subunit
vaccine preparation in 40 /ll of saline. Immunizations were given at 6 weeks, 14, 7 or 1
day of age. Serum was collected at 4 weeks post-prime and assayed for anti-influenza-
specifc IgG Ab responses by ELISA. Data are for individual mice.
immunized with the pJW4303 empty vector DNA succumbed to flu infection by 4-
days post-challenge. Survival of both adult and neonatal HA DNA-immunized mice
was dependent on anti-HA-specific IgG pre-challenge titers. Similar titers 
antibody conferred protection in both groups (Figure 7).
DISCUSSION
In this chapter we show that both intramuscular and gene gun immunization of
newborn mice with HA DNA elicits vigorous, long- lasting, protective anti-HA-
specifc IgG responses comparable in titer, but different in isotype, to those generated
in adult HA DNA-immunized mice. In contrast to the strongly polarizd IgG2a and
IgG 1 responses following adult im. and g.g. DNA inoculations, newborns generated
a variety ofIgGl , IgG2a and mixed IgGI/IgG2a responses regardless of the method
of DNA inoculation. Also in contrast to adult immunizations, neonatal mice failed to
respond to various doses of an NPR/8/34 subunit vaccine. Responsiveness to protein
vaccination and development of polarizd patterns ofT help following DNA
immunization appeared by 2 weeks of age.
Mice DNA- immunized as adults and neonates had similar antibody titers but
different isotype profies. Adult HA DNA immunized mice generated the expected
strongly polarized IgG2a and IgG 1 responses following Lm. and g.g. inoculation
respectively. Interestingly, both im. and g.g. inoculation of neonatal mice generated
100
Pup Lm. Pup 
Adultl Lm. Adult g. D
pJW4303 (Pup and Adult) 
:. 
I Survival I
Day of death
Figure 7. Correlation of anti-HA-specific IgG levels and protection from influenza
challenge. One-day- and 8 week-old mice were immunized with HA-DNA by Lm. (25
Jlg) or g.g. (1 Jlg). Eight to 9 months later, mice were challenged i.m. with a lethal dose
of NPR/8/34 and weighed daily. Mice were sacrifced following :;20% loss of pre-
challenge body weight. Serum was collected and assayed for anti-HA-specific IgG titers
by ELISA prior to virs challenge.
a variety of IgG 1 , IgG2a, and mixed IgG l/IgG2a responses. The profies raised by the
prime persisted following the boost. The combination of both IgG 1 and IgG2a responses
following g.g. DNA immunization was particularly unexpected. Neonates typically have
IgG 1 biased responses following immunization with many types of vaccines (Barrios 
ai., 1996b; Siegrist et al., 1998b; Singh, Hahn, and Sercarz, 1996), and g.g. DNA
inoculations typically raise Th2 biased responses in adult animals (Feltquate et ai., 1997;
Pertmer, Roberts, and Haynes, 1996).
We do not understand the differences in the biases of the IgG responses that
occurred within the same litter using identical delivery conditions. Very few APC may
be required to initiate a response following DNA immunization in the neonate. APC as
ll as the lymphoid organ are stil undergoing development at birth. Macrophages and
B cells, for instance, are known to be deficient in antigen processing and presentation
functions including co-stimulation (Lu, Calamai, and Unanue, 1979; Schelonka and
Infante, 1998; Trivedi et ai., 1997). The various Th types of the DNA-raised responses
may reflect this ongoing development. The specifc APC transfected within a paricular
neonate may be in a different stage of development than the APC in a littermate, which
may subsequently affect IgG isotype development. In contrast, adults have fully
differentiated APC and lymphoid organs, which may account for the highly polarized
responses raised in these animals.
Previous studies have shown different dominant Th types elicited by Lm. DNA-
immunization of neonatal mice. Two reports show differences in IgG isotype responses
from mice DNA- immunized as pups or in adulthood. DNA encoding the herpes simplex
virus gB elicited mainly an IgG2a response in adult-immunized animals and a mixed
IgG l/IgG2a response in pooled serum from mice immunized as newborns (Manickan
Yu, and Rouse, 1997). Likewise, adult mice immunized with DNA encoding
hemagglutinin from the WSN strain of influenza gave a predominant IgG2a response,
and mice immunized as neonates gave a mixed IgGI/IgG2a response (Bot et al., 1997).
These two reports paralel the data shown in Tables 2 and 3. However, Wang et at.
(1997) reported a strong IgG2a profIe in pooled serum from mice immunized with a
rabies virs gp-DNA at 1 day or 6 weeks of age. Marinez et at. (1997) also showed
equivalent IgG subtypes in pooled serum from mice immunized as adults or pups, but
subtypes were dependent on the type of antigen being encoded by the plasmid DNA
Both measles virus hemagglutinin and Sendai virs nucleoprotein DNAs generated IgG2a
responses, whereas DNA encoding the C fragment of tetanus toxin elicited a mixed
IgGI/IgG2a profIe. Differences observed in dominant Th profIes in different
experimental models may be antigen-specific and/or may reflect the use of pooled vs.
individual mouse serum. Importantly, none of the groups showed a consistent,
predominant IgG 1 profIe which indicate DNA vaccines are capable of circumventing the
Th2 bias elicited in newborns with other vaccine antigens (Barios et ai., 1996b).
Inherent defects in neonatal APC may account for the differences in effcacy of
neonatal protein and DNA immunizations (Schelonka and Infante, 1998; Trivedi et ai.,
1997). Studies using soluble pigeon cytochrome show that splenic B cells are unable to
internalize, process and present the antigen unti10- 14 days of age and adult levels do not
occur until 21-28 days of age. Furthermore, presentation of a pigeon cytochrome peptide,
which does not require processing, occurs at 50% of adult levels by 7 days and is at 100%
by 14- 18 days of age. These data also correlate with temporal MHC class II, ICAM-
and LFA- l cell surface expression (Hoyer, Morris, and Pierce, 1992; Morris, Hoyer, and
Pierce, 1992). Thi time course supports data presented in Figure 6 which shows that HA
protein-immunized mice generate low-level IgG responses when immunizd between 7
and 14 days of age. In contrast to protein that must be taken up by cells for presentation
plasmid DNA can directly transfect APC that are either resident in or circulating through
the target tissue. DNA vaccines are also different from protein vaccines in that the
DNA-encoded protein is expressed for relatively long periods of time (Wiliams et al.,
1991; Wolff et al., 1990); T. Pertmer, unpublished observations). Therefore, the presence
of newly generated antigen at later times in ontogeny may circumvent the defects
associated with APC at earlier time points and allow for antigen presentation. The long-
term presence of antigen may also account for the longevity and stabilty of the humoral
responses generated following DNA immunizations.
CONCLUSION
These findings suggest that newborn mice developed stable, long-lived , protective
anti-HA-specific IgG responses similar in titer to those of adult DNA-immunized mice.
However, unlike the adult Lm. and g.g. DNA immunizations, which develop polarizd
IgG2a and IgG 1 responses respectively, mice immunized as neonates developed a variety
of IgGl-, IgG2a-, and mixed IgGI/IgG2a responses, regardless of the inoculation
method. Boosting increased but did not change these antibody profies. In contrast to the
DNA immunizations, inoculations of newborn mice with an NPR/8/34 viral protein
subunit preparation failed to elicit an antibody response. Temporal studies revealed that
both responsiveness to protein vaccination and development of polarized patterns of T
help following DNA immunization appeared by 2 weeks of age.
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CHAPTER II:
THI GENETIC ADJUVANTS MODULATE IMMUNE RESPONSES
IN NEONATAL MICE
HYPOTHESIS
The disparity between adult and neonatal DNA-raised IgG responses is due to a
deficiency in Thl-type cytokines at birth, and thus, it is possible to overcome this
deficiency by codelivering Thl genetic adjuvants at the time of DNA immunization.
INTRODUCTION
In the previous chapter, we examined the ability of neonatal mice to generate
protective IgG responses following DNA immunization. We showed that newborn mice
developed stable, long- lived , protective anti-HA-specifc IgG responses similar in titer to
those of adult DNA- immunized mice. However, unlie the adult i.m. and g.g. DNA
immunizations which develop polarized IgG2a and IgG 1 responses, respectively, mice
immunized as neonates developed a variety of IgGl- , IgG2a- , and mixed IgGI/IgG2a
responses , regardless of the inoculation method. It is unclear why this disparity in IgG
subtype profiles exists.
One theory that accounts for the disparity between neonatal and adult IgG subtype
responses is related to their deficiencies in many components of innate, specific, and
2 The data presented in this chapter have been submitted for publication.
inflammatory immune responses. For instance, one of the areas of deficiency is in Thl-
type cytokines. This is exemplified in one study, which addressed the expression and
production of IL- 12 in human cord blood cells following LPS stimulation. When cord
blood cells were compared to adult PBMC, it was found that the levels of p40 mRA
were similar in both groups, but cord blood cells produced p40 mRNA transcripts with a
shorter half life. Thus, the deficiency in neonatal IL- 12 production was due to post-
transcriptional regulation (Suen et ai., 1998). Similarly, another group (Pioli et ai., 1998)
showed that older mice produce more IFNy than young mice, and the difference was
attributed to different IFNy mR A stabilty patterns.
The studies in this chapter were undertaken to determine if it possible to
overcome the Thl cytokie deficiency in neonates. IL- 12 is the predominant force
behind Thl-type immune responses. IL- 12 induces IFNyproduction by both NK and T
cells and has multiple biological effects on the immune system. Thus, both of these
cytokies have obvious potential benefits for overcoming the Thl deficiency in neonates;
however there are very little data to support the use of these cytokines in neonates. The
use of DNA as vaccine and adjuvant may be better suited for use in neonates, as the Thl
cytokies wil co-localize with the vaccine antigen at the site of antigen presentation.
Although effective (Arulanandam, Cleave, and Metzger, 1999; Kovarik et al., 1999),
recombinant cytokies are typically administered systemically and have the potential for
serious side effects in infants (Kovarik et ai., 2000). We show that both codelivered
IFNyand IL- 12 DNA polarized the isotype patterns of anti-HA antibody in neonates to
T .
IgG2a, but did not affect isotype patterns in adults. Additionally, we show that
codelivery of the Thl genetic adjuvants biased the pattern of cytokine production by
restimulated splenocytes more strongly toward IFNy in neonates than adults.
RESULTS
Neonatal mice immunized with HA DNA lack polarized IgG responses.
One-day-old and 12-week-old mice immunized by either i.m. (10 /lg HA DNA)
or g.g. (1 /lg HA DNA) inoculation generated HA-specific IgG responses that were
comparable in magnitude but had different isotype profIes (Table 3). Mice immunized at
12 weeks of age by i.m. inoculation had a dominant IgG2a response; whereas g.
immunized mice had a dominant IgG 1 response. In contrast, mice immunized at 1 day of
age differed in the isotype profie of their responses, with some mice generating
predominantly IgGl , some, predominantly IgG2a, and some overall similar levels of
IgG 1 and IgG2a irrespective of the method of immunization. The observed isotype
profIes of each group were stable for at least 1 year and conftrmed our previous results
from Chapter 1 (Pertmer and Robinson, 1999).
Neonatal mice coimmunized with DNAs expressing HA and Thl-promoting cytokines
develop polarized IgG2a responses.
To determine if the deficiency of Thl-promoting cytokines at birh played a role
in the lack of polarized IgG responses in neonatal mice, newborn mice were
co immunized with DNAs expressing HA and the Thl-type cytokies, IL- 12 or IFNy.
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The IL- 12 plasmid was bicistronic and encoded both the p35 and p40 subunits ofIL- 12.
Mice immunized by i.m. inoculation received 10 jlg of HA- and 40 jlg of cytokie-
encoding DNA, while g. immunized mice received Ijlg ofHA- and 4jlg of cytokie-
encoding DNA. Control groups received empty vector DNA (control DNA) in the place
of the cytokine DNA. Results are from a single experiment.
In contrast to the lack of polarized IgG responses in HA DNA immunized
neonates, mice coimmunized on the day of birth with HA DNA and IL- 12- (im.
pc:O.001; g.g., p=0.02) or IFNy- (i. , p=O.OOI; g.g., p=0.2) DNA developed strongly
polaized IgG2a responses (Figure 8, Table 3). This occurred in groups receiving either
im. or g.g. inoculations. For instance, in mice co immunized on the day of birh with IL-
12 DNA, 8/9 Lm. immunized and 10/10 immunized mice developed predominantly
anti-HA IgG2a responss. The IgG2a polarization seen following neonatal Lm.
codelivery oflL- 12 DNA was transient. By 1 year post-prime, IgG profies had reverted
to the mixture of responses seen in mice immunized with HA DNA alone (Table 3). This
reversion was not seen in the neonatal g. immunized mice, where the IgG2a-
predominance remained stable in 9110 mice for up to 1 year. The IgG2a polarization of
responses also was stable over the course of a year in mice receiving codelivered IFNy
DNA (Figure 8, Table 3).
Unlike neonatal mice, codelivery of HA DNA and IL- 12- or IFNy-DNA in adult
mice had no effect on the polarized patterns of IgG responses in Lm. or g.g. DNA-
inoculated mice (Figure 8 , Table 3). As expected, virtually all Lm. inoculated mice had
polaized IgG2a patterns. However, 100% of the adult mice co immunized by g.g. with
IL- 12- or IFNy-DNA retained an IgGl-biased anti-HA antibody response. These
polarized patterns did not change over the course of a year. Thus, Thl-promoting DNA
adjuvants had a greater influence on IgG subtype polarization in neonates than adults.
Both neonatal and adult mice coimmunized with Thl cytokines have increased Thl-
type cellular immune responses.
We further addressed the effect ofThl cytokie DNA codelivery on immune
responses by testing for cytokine responses following stimulation of PBMC with
inactivated influenza virus. Vaccinated mice were challenged with a sublethal dose of
influenza virus. One week later, splenocytes were pooled from 2-3 mice and cultured for
2 days with inactivated influenza virs. Culture supernatants were harested, pooled and
assayed by ELISA for IFNy (indicative of a Thl response) and IL-5 (indicative of a Th2
response) (Figure 9, Table 4). This assay tested for lymphokine pattern of the secondary
response recalled by a viral infection.
Codelivered IL- 12 DNA had a stronger effect on the lymphokine responss 
restimulated splenocytes than codelivered IFNy DNA (Table 4). In both neonates and
adults, codelivery of IL- 12 DNA completely inhibited the abilty of recalled splenocytes
to produce IL-5. This was true for Lm. (adults, pc:O.Ol; pups, pc:0.02) and g.g (adults, p
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Figure 8. Isotype profIes of mice immunized with HA DNA with or without Thl
genetic adjuvants. One-day-old and 12-week-old mice were Lm. or g.g. imunized
with DNAs expressing HA and either pJW, IL-12 or IFy. Serum was collected at 16
weeks post-prime and assayed by ELISA for IgG 1 and IgG2a. Mice were scored
IgG I-predominant if the ratio of IgG 1 to IgG2a was , scored IgG2a-predominant
ifthe ratio oflgG 1 to IgG2a was 5, and scored 'Mix' if the ratio ofIgG 1 to IgG2a
was between 0.5 and 2.0. See also Table 3.
I;Mix
. IgG2a
Control IL- IFNg
Codelivered DNA (+HA)
100 mm..m
Control IL- IFNg
Codelivered DNA (+HA)
:::: .... 
il!
)  -%' :;=:
Control IL- IFNg
Codelivered DNA (+HA)
100
Control IFNgIL-
Codelivered DNA (+HA)
.:0.01; pups, p=0.05) deliveries of DNA. In contrast, codelivery of IFNy DNA
completely inhibited IL-5 production in recall responses in neonates (p=0.002) but not
adults (p=0.24). In i. immunized adults, the codelivered IFNy DNA had no effect on
the relative production of IFNy (p=0.34) and IL-5 (p=O. 13) in the recall responses.
However, in g. immunized adults codelivery of IFNy DNA did increase the ratio of
IFNy to IL-
DISCUSSION
We have previously shown in Chapter 1 that both Lm. and g.g. immunization of
neonatal mice generate a variety ofIgGl , IgG2a and mixed IgGI/IgG2a responses;
whereas adult mice have polaized IgG2a- and IgGl-predominant responses following
im. and g.g. immunization, respectively (Pertmer and Robinson, 1999). In this chapter
we evaluate the abilty of codelivered Thl-promoting cytokie DNAs to bias immune
responses toward Thl. Our results show that codelivery of HA and IL- 12 or IFNy DNA
in neonates elicits predominantly IgG2a responses, while codelivery in adults has no
effect on IgG subtype patterns (Figure 8 , Table 3). Our results also show that codelivery
of IL- 12- or IFNy -DNA in neonates causes a marked shif towards production of IFNy;
whereas codelivery ofIL- 12 DNA has a much stronger effect than codelivery oflFNy
DNA in adults (Figure 9, Table 4).
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Table 4. CD4+ T cell responses following immunization with DNAs expressing
influenza HA and Thl cytokines
Codelivered Age at IFNy IL- Ratio
DNA immunization Method pglmI) (pglmI) (IFNyII
Control 1 day i.m 445 1380* 395 1280* 1.111.3
385 215 1.8
12 weeks i.m 1005 220
3775 2220 1.7
IL- 1 day i.m 170 170
440 440
12 weeks i.m 5615 5615
830 630
IFNy 1 day i.m 265* 00* 265
1665 1665
12 weeks i.m 1420 625 2.3
2815 240 11.7
Control only m/g. 00 00 100*
*Results from an independent experiment
Splenocytes from the sae mice used in Figure 8 were cultured for 2 days with inactivated influenza virus.
Bulk culture supernatats were harvested and pooled and assayed for IFyand IL-5 production by ELISA.
Reults are shown as mea IFyand IL-5 levels in culture superntats. See also Figure 9.
Codelivery ofThl cytokine DNA affected IgG isotype profies in neonates, but
not adults. Neonatal mice immunized with HA and control DNA had a variety of IgG 1
IgG2a and mixed IgG lIIgG2a response, as opposed to the strongly polarized responses
of adult immunized mice (Table 3 , Figure 8). Codelivery of either IL- 12- or IFNy-DNA
in neonates directed the isotype responses to an IgG2a-predominance. These results are
consistent with a recent study showing that administration of recombinant IL- 12 with
protein antigens in neonatal mice redirect an IgG 1 to an IgG2a-predominant response
(Arlanandam, Cleave, and Metzger, 1999). In contrast to the studies in neonates,
codelivery of the Thl cytokie DNAs failed to redirect IgG 1 responses to IgG2a in
adults. These results imply that antibody responses generated by immature immune
systems are more susceptible to modulation by exogenous IL- 12 and IFNy than antibody
responses raised by mature immune systems. This could reflect exogenously introduced
cytokies having larger impacts on lymphokine levels in neonates because of the low
levels of expression of endogenous IL- 12 and IFNy in immature murine lymphoid cells
(Pioli et al., 1998; Suen et ai., 1998).
Lymphokine responses of recall splenocytes were more sensitive to
immunizations in the presence of codelivered cytokines than isotype responses. Whereas
effects on isotype profIes were limited to neonates, effects on cytokie production were
observed in both neonates and adults. Codelivered IL- 12 DNA resulted in the absence of
IL-5 production by recall splenocytes in both age groups (Table 4, Figure 9). A recent
study by Kovarik, et al. also showed a decrease in IL-5 responses following codelivery of
IL- 12 DNA (Kovarik et ai., 1999). Codelivered IFNy DNA had a stronger effect in
neonates than adults, blocking IL-5 production by recall splenocytes in mice immunized
as neonates but only modulating the recall response in mice immunized as adults (Table
, Figure 9).
The effects of codelivered cytokies on antibody and T cell responses revealed
isotype patterns that did not necessarily correlate with cytokie responses. In adult mice
coimmunized with IL- 12 DNA, a predominantly IgG 1 antibody response occurred in
mice whose recall splenocytes produced high levels of IFNy but undetectable levels of
IL-5. Thus , a Th2 isotype (IgGl) was associated with a Thl (IFNy) pattern of
lymphokines. This "dichotomy" in isotype and lymphokine responses was also observed
in neonates immunized in the presence of codelivered IL- 12. By one year of age, IgG
isotypes had reverted to a mixed pattern, whereas the cytokies remained exclusively
IFNy. These results imply that recall T cells do not necessarily reflect the population of T
cell that provided help for the memory B cell response. Similar results have been
observed previously (Laylor et ai. 1999; Pertmer, Roberts, and Haynes, 1996).
Coadministration of genetic adjuvants may have a stronger effect on the
establishment of recall responses than coadministration of lymphokine proteins.
IL- 12 coadministration with a protein antigen induces a primary Thl response in adult
mice; however, the recal response was a ThO response despite subsequent immunizations
with IL- 12 (Bliss et ai., 1996; Wolf et ai., 1995). In our study, mice co immunized with
HA and IL- 12 or IFNy DNAs had a Thl-predominant recall response (Figure 9 , Table 4).
Despite the dichotomies in the phenotypes of some of the memory Band T cell
responses in our study (see above), our results clearly demonstrate that codelivery ofThl
genetic adjuvants can direct neonatal immune responses in mice towards type 1 T cell
help. Interestingly, within our sample sizes, the most defmitive and consistent long term
establishment of Thl responses in neonates was achieved by coinoculation of IFNy DNA
not IL- 12 DNA, as evidenced by the production of IgG2a antibody and the presence of
recall IFNy-producing splenocytes. In contrast, the most pronounced long term effects on
the Th-type of the raisd response in adults was seen for coinoculated IL- 12 DNA
CONCLUSION
In this chapter, we addressed the abilty of DNA encoding Thl cytokines to bias
the immune responses raisd by neonatal DNA immunization. These studies were
undertaken to determine if it possible to overcome the Thl cytokine deficiency in
neonates. Neonatal mice co immunized with HA DNA and either IL- 12 or IFNy-
expressing DNA developed IgG2a-biased immune responses, regardless of inoculation
method. In contrast, the Thl genetic adjuvants had no effect on IgG subtype pattern in
adults. In neonatal mice, the Thl genetic adjuvants also shifted the pattern of
lymphokine production by recall splenocytes from a mixed response of IFNy and IL-5 to
exclusively IFNy. In adults, despite the failure to change the isotype pattern of the
antibody response, a shift towards IFNy production also occurred for recal splenocytes
following coimmunzation with IL- 12. Thus, coinoculation ofThl genetic adjuvants had
greater effects on the nature of the immune response in the neonate and were more
marked than the effects in adults.
CHAPTER III:
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CHAPTER III:
CHARACTERIZATION OF IMMUNE RESPONSES TO
INFLUENZA DNA VACCINES
IN THE PRESENCE OF MATERNAL ANTIBODy
HYPOTHESIS
DNA vaccines are effective in generating both humoral and cellular immune
responses in the presence of maternal antibody.
INTRODUCTION
Neonates are deficient in several components of inammatory and innate and
specifc immune responses. The presence of high titer maternal antibody in newborns is
the major form of protection from disease in early life. Maternal IgG crosses the placenta
from mother to fetus durig development (Leach et al., 1996) and typically exceeds titers
of the same antibody in the mother. This passive antibody slowly declines over the fIrst
year of life, a period durig which the infant's immune system matures , becomes more
experienced , and develops it s own repertoire of protective memory immune responses.
However, maternal antibody can also interfere with active immunization of the offspring
(Albrecht et al., 1977). Immunization protocols are often delayed several months and/or
require multiple booster immunizations to achieve the desired protective immune
3 The data in this chapter have been submitted for publication.
respons. Thus, a window of time exists when maternal antibody levels are too low to
reliably protect an infant from infectious disease but are high enough to prevent
responses to vaccines.
DNA vaccination is an attractive method for immunization in the presence of
maternal antibody. Maternal antibody is thought to interfere with traditional vaccine
effcacy by reducing the amount of antigen available for processing and presentation by
antigen presenting cells. The abilty of DNA vaccines to directly transfect cells bypasses
this problem. The maternal antibody wil not inhibit the DNA vaccine itself because
antigen is not available until de novo synthesis occurs. Both DNA and subseuent
antigen expression persists for several weeks (Doe et al., 1996). Thus, DNA-raisd
immune responses could occur as maternal antibody titers wane. Some groups have
reported success following neonatal DNA immunization in the presence of maternal
antibody (Manickan, Yu, and Rouse, 1997), while others have failed (Le Potier et al.
1997; Monteil et al., 1997; Siegrist et ai., 1998a; Wang et ai., 1998).
We have previously shown in Chapter 1 that Lm. and g.g. immunization of mice
as neonates or adults with an influenza hemagglutinin (HA)-expressing DNA generates
long-lasting protective IgG responses (Pertmer and Robinson, 1999). In this study, we
address the abilty of DNAs expressing HA and nucleoprotein (NP) to generate humoral
and cellular responses in the presence of maternal antibody. When expressed in a DNA
vaccine, the influenza HA localizes to the plama membrane while the influenza NP is
intracellular. Our results show an inhibition of DNA-raised antibody responses to HA
which correlates with the amount of maternal antibody at the time of immunization.
However, the presence of maternal antibody did not affect the generation of antibody to
NP or the generation of long-lived cellular immune responses to HA or NP.
RESUL TS
Maternal antibody inhibits IgG responses to HA but not NP.
Mice born to influenza-immune mothers vaccinated on the day of birh were
deficient in the generation of DNA-raised IgG to HA but not NP (Figure 10, Table 5).
One-day old mice born to naIve mothers or influenza-immune mothers were immunized
on the day of birth by Lm. or g.g inoculation with HA, NP or HA plus NP DNA At the
time of DNA immunization, the geometric mean titer (GMT) of anti-influenza maternal
IgG in the neonates was 128.5 Jlg/ml (107. , 150. 95% confdence limits). By 12
weeks of age, the titers had fallen to background levels. At 30 weeks post-prie, the
neonates immunized in the presence of maternal antibody showed different patterns of
IgG responses to HA and NP than those immunized in the absence of maternal antibody.
In the maternal antibody positive groups, the highest antibody responses were seen for
, the second highest for HA plus NP, whereas no responses were seen for HA (Figures
, AB). By contrast, in the maternal antibody negative groups, the highest antibody
responses were seen for HA plus NP, the second highest for HA, and the lowest for NP
(Figure 10, AB).
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Table 5. IgG responses following DNA immunization in the presence or absence of
maternal antibodl.
(llg/ml)
Age at Maternal Ab Maternal Ab
immunization DNA Method resent absent Ratiod,e
1 day Lm. 6 (0. 2, 0. 2 (6. 8, 12.
0.4 (0. 1 (3.9, 12.4)
Lm. 5 (1.9, 3. 3 (5.
2.4 (1.9, 3. 1.1 (0.9, 1.4)
12 weeks 2 (5.7, 10. 12.9 (10. 2, 16.
0 (1.5, 2. 5 (2. 0.4
Lm. 3 (3. 5 (3.8, 5.4) 1.0
6 (4. 5 (2. 6, 4. 1.3
a Mice were imunized and IgG levels were assayed as given in Figure 1. Results are shown as GMT of
IgG for groups of 7 -14 mice at 30 weeks post-prime.b GMT of IgG of mice born to influenza-imune mothers (95% confidence lits).
GMT of IgG of mice bo to naIve mothers (95% confidence lits).d Ratio = (IgG levels in DNA-imunized mice born to influenza-imune mothers) : (IgG levels in DNA-
imunized mice born to naIve mothers).
Differences between the effects of maternal antiboy on HA- and NP-raised IgG responses was
significat Lm. , po:O.02; g.g., poO.OOl (ANOV A replicated, two-way analysis of variance).
Direct comparison of the titers of the antibody responses for HA and NP in the
groups immunized as neonates revealed that maternal antibody had limited antibody
responses to HA but not NP (Table 5). In both g.g. and i.m. immunized neonates, the
levels of anti-HA IgG had been reduced by 16-fold. By contrast, the maternal antibody
had not significantly reduced antibody responses in the groups immunized with NP.
Differences between the effects of maternal antibody on HA- and NP-raised IgG
responses was significant (Lm., pc:0.02; g. g., pc:0.001; ANOV A replicated two-way
analysis of variance).
Mice born to influenza-immune mothers and DNA-immunized as young adults,
when maternal antibody had decreased to background levels, generated antibody to both
HA and NP (Figure 1O,CD). The ratios of antibody responses to HA and NP revealed
that the blocking effect of maternal antibody on the raising of anti-HA IgG had ben
largely lost (Table 5).
Analysis of the kinetics of antibody responses in the various groups revealed that
the method of DNA delivery, the age of the mouse at the time of DNA immunization, and
the presence or absence of maternal antibody all affected the time course of the
appearance of antibody (Figure 10). Naive mice Lm. immunized on the day of birh
developed IgG responses within 8 weeks, whereas g. immunized mice did not generate
detectable responses unti 12 weeks of age (Figure 10, AB). Mice immunized as
neonates required approximately 4 weeks longer to generate IgG than mice immunized as
young adults. Neonates developed antibody by 8 weeks following i.m. delivery of DNA;
whereas young adults developed antibody by 4 weeks. Following gene gun
immunizations, neonates developed antibody by 12 weeks; whereas young adults
generated antibody within 8 weeks. The presence of residual maternal antibody in the
young adults also slowed the appearance of antibody by about 4 weeks (Figure 10, CD).
Optimization of methods to characterize CD8+ T cell responses.
We next wished to determine if anti- influenza maternal antibody was capable of
preventing DNA-raied T cell responses; however, it was fIrst necessary to optimize the
method for detecting these responses. The popula method of determining the magnitude
of an antigen-specific CTL response by Cr release is qualitative. Until recently, the
only way to determine the frequency of CTL was by limiting dilution assay (LDA).
However, this method has the potential to underestimate the number of antigen-specific T
cell because it does not detect non-prolierating cells (Altman et ai., 1996; Mural-
Krishna et ai., 1998). Although LDA has ben sufficient for quantitating CTL in acute
viral infections, it is liely not the best method for determining the expected lower
frequencies ofCTL following DNA-based immunizations. Recently, a novel method of
detecting antigen-specific T cell response has ben developed cells (Altman et ai., 1996;
Murali- Krishna et ai., 1998). This method uses soluble tetrameric MHC class I-peptide
complexes to bind specifcally and stably to the appropriate MHC class I-peptide-specifc
CD8+ T cells. This technique allows for direct visualization of antigen-specific T cells
and requires no in vitro restimulation.
In a preliminary experiment, mice that had ben either Lm. or g.g. co immunized
with HA plus NP DNAs were sublethally infected -35 weeks post-immunization to
activate memory T cells. Seven days later, splenocytes were prepared and cultured for
10- 12 hours with K -restricted HA or NP peptides, or in media without peptides. The
fmal 5-6 hours of culture included Monensin (Pharmingen, San Diego, CA), which
inhibits protein transport and allows for the accumulation of intracellular cytokies. The
cells were surface stained for CD8 and 1 of 2 types of tetrameric complexes, H-
HA533-541 (HA-tet) or H- 147 155 (NP-tet). The cells were then permeabilzed
stained for intracellular IFNyand analyzed by flow cytometry.
Mice DNA-immunized with HA plus NP develop antigen-specific CD8+ T cell
responses (Figures 11 and 12). As shown in Figure 11 , mice immunized by Lm. or g.
inoculation had 2.09% and 0.83% ofCD8+ cells that were HA-tet , respectively. The
HA-tet+ cell were IFNy- following stimulation with media only. However, following
HA peptide stimulation, there was an expected TCR down-regulation and a shift to HA-
ter, IFNy+ phenotype in both Lm. and g. immunized mice. Similar, yet more
pronounced, results were seen using NP tetramers (Figure 12). Mice immunized by Lm.
or g.g. inoculation had NP-tet+ frequencies of 4.26% and 1.67%, respectively. As seen
with HA, NP peptide stimulation caused a massive TCR down-regulation and a shift to
NP-ter, IFNy+ phenotype. In both cases, the frequencies of IFNy+ CD8+ cells following
peptide stimulation corresponded with the frequencies of tet+ cell prior to peptide
M. HA+NP G. HA+NP NAIVECHE
. .. ... 
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HA peptide
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Figur 11. HA te to qutate HA-speifc CDS+ T cel renses followg HA plus
NP DNA cover. Mice were i.m. or g.
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infeced with infuen vi -35 weeks late to actvate memoy ceUs. Seven days later,
splenocytes were cultued for 10-12 ho with med or a K"-restrcted HA petide. The cells
were suace stned with CDS-PE and AP-labeed HA tetamec. The cells were
pemeabili sted for intracelular lFyor ITA an anyz by flow cytomey. One
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Table 6. Tetramer positive cells correlates with IFNy positive cells following peptide
stimulation
FACS (%) FACS (%)
Method Stimulation HA-tet+ IFNy+ Specific NP-tet+ IFNy+ Specific
sis sis
Lm. Meda 1.5
52% 34%
Peptide 1.7
Meda
11 % 44%
Peptide
Mice were coimunized with HA plus NP and sublethally challenged -35 weeks later. Splenocytes were
prepared and stiulated as given in Figures 11 (HA) and 12 (NP).
HA-tet+, HA-tetramer positive.
NP-tet+, NP-tetramer positive.
Data are shown as (% Tet+ in imunized mice) mius (average % Tet+ of naIve mice) both before and
afer stiulation with appropriate peptide.
Data are shown as (% IFNYI- in imunized mice) minus (average % IF"f in naIve mice) both before and
afer stiulation with the appropriate peptide.
r Data are for the 12.
5:1 effector:taget ratios of StCr-releae assay shown in Figure 13. Data are (%
speific lysis of imunized mice) minus (% specific lysis of naIve control).
stimulation (Table 6). There was only minimal background staining in naive animals
and none ofthe groups had a Tc2 phenotype (Mosmann et ai., 1995; Mosmann et ai.,
1997) as determined by IL-4 intracellular staining (Figures 11 and 12).
Frequencies of tetramer positive cells correlated with kiling activity (Figure 13).
Aliquots of cells used in Figures 11 and 12, were further analyzed by chromium-51 e Cr)
release for antigen-specifc kiling activity. Target p815 cells were pulsed with the K
restricted peptides HA533-541 or 147 155. Gene gun immunized mice had HA CTL
responses slightly above background, yet very high NP CTL responses, which correlates
with the lower frequency of HA-tet+ cells and high frequency of NP-te( cell shown in
Figures 11 and 12. Similarly, Lm. inoculated mice had good kiling of both HA and 
targets. Taken together, these data suggest that tetramer staining is a good measure of
antigen-specifc T cells, and that the frequencies oftet+ T cells (or IFNy ) T cell
correlate with antigen-specific kiling activity.
Maternal antiody does not block the generation of long-lived CD8+ T cell responses.
We next determined if anti-influenza antibody was capable of preventing DNA-
raised T cell responses. Mice born to naive or influenza-immune mothers were DNA-
immunizd as described in Figure 10 by im. or g.g. with HA- and/or NP-expressing
DNA. One year later, mice were inoculated with a sublethal dose of influenza NPR/8/34
virs to activate memory T cells. Mice were sacrifced 7 days later, and spleens from
each group (n=2-3) were pooled. Splenocytes were cultured for 10- 12 hours with K
100
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Figure 13. HA- and NP-speific killng following HA plus NP DNA coimmunization. Aliquots
of splenocytes from mice described in Figues 11 and 12 were fuer anlyzed in a chromium
releae assay. The splenocytes from these mice were cultued with the K -restricted HA or NP
petide-pulsed stimulator splenocytes from syngeneic mice. Five days later, the effectors were
cultued for 4 hours with Cr-Iabeled, HA- or NP-peptide pulsed p815 taget cells. Cultue
supertants were measured for radioactivity in a scintillation counter. Results are shown as
pecent speific lysis +1- SD at various effector to target rations (see Materials and Methods).
restricted HA or NP peptides. The fmal 5-6 hours of culture included Monensin
(Pharmingen, San Diego , CA), which inhibits protein transport and allows for the
accumulation of intracellular cytokines. Because it was shown previously (Figures 11-
12) that tetramer positive CD8+ T cells prior to peptide stimulation corresponded with
IFNy+ following peptide stimulation, we decided to rely on IFNy staining only, as both
HA and NP tetramers were unstable. Thus, the peptide stimulated cells were instead
surface stained for CD8B and CD69 (an early activation antigen), permeabilzed, staied
for intracellular IFNy and analyzed by flow cytometry. Results are from a single
experiment.
Maternal antibody did not block the generation of long-term CD8+ T cell
responses to DNA expressed HA or NP (Figures 14 and 15, Table 7). Immunizations
with HA, NP, or HA plus NP DNA in the presence or absence of maternal antibody
generated overall comparable frequencies of antigen-specific CD8+ T cells. Variation
was seen between groups in the frequencies of responding T cells. However, this
variation had no consistent pattern between groups born to naIve or influenza-immune
mothers. Data were also similar between mice immunized as neonates or as young
adults. Analysis of the geometric means of the frequencies of responding T cells (Table
7) revealed higher frequencies in the g. immunized groups (p.cO.OI). Overall, the
frequencies of responding cells for HA and NP were not affected by HA- plus NP DNA
codelivery (HA, p=0.6; NP, p=0.5).
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Figure 14. Effects of maternal antiboy on Lm. DNA-raised CDS+ T cell responses, as determined by
intrcellula cyokine staing. Mice born to naive or influenza-imune mothers were imunized on
the day of birth or in adulthoo by (top) Lm. inoculation with HA and/or NP DNA or (bttom)
pJW4303 control DNA One ye late, mice were inoculated with a sublethal dose of influenza vis.
Mice were sacrifice 7 days later, and spleens from each group (n=2-3) were poled. Splenocytes were
cultured for 10-12 hous with a Kd-restricted HA or NP peptide as appropriate. The final 5-6 hours of
culture included Monensin, which inibits protein trspo by golgi and alows' for the accumultion of
intrcellula cyokines. The cells were surface staed for CDS and CD69 (ealy activation antigen) then
permeabilied and staed for intracellular IFyand analyz by flow cytometr. Data are shown as
dot plots with numbes in quadrants represntig the respetive pecent of the CDS+ cell population.
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Figure 15. Effects of maternal antiboy on g.g. DNA-raise CD8+ T cell response, as deteed 
intrcellula cytokie staing. Mice bo to naIve or influenza-imune mothers were imunized on the
day of bi or in adulthoo by (top) g.g. inoclation with HA and/or NP DNA or (bttom) pJW4303
control DNA. One ye later, mice were inoculated with a sublethal dose of influenza vius. Mice were
sacrfice 7 days late, and spleens from each group (n=2-3) were poled. Splenocytes were cultured for
10-12 hours with a K -restrcted HA or NP peptide as approprite. The fial 5-6 hours of culture included
Monensin which inibits protein trspot by golgi and alows for the accumulation of intrcellular
cytokines. The cells were surface staed for CD8 and CD69 (ealy activation antigen) then peeabilized
and staed for intrcellula IFrand analyzed by flow cytometr. Dat are shown as dot plots with
numbes in quilClrants repesntig the respetive percent of the CD8+ cell population.
r -
The production of IFNy in culture supernatants correlated with intracellular
cytokine FACS data (Figure 16, Table 7). The same groups of pooled splenocytes from
DNA-immunized mice described in Figures 14 and 15 were cultured for 2 days with the
-restricted HA or NP peptides. Supernatants from duplicate wells were pooled and
assessed for IFNy by ELISA. IFNy production was easily scored for all groups. Analysis
of the ratios of IFNy production per IFNy-producing CD8+ cell revealed that g. -raised
cells produced more IFNythan Lm.-raised CD8+ cells (pocO.OOI; Table 7). This
phenomenon was particularly marked for T cell responses to NP (pocO.02).
Maternal antibody does not inhibit the generation of T helper responses.
The presence of maternal antibody at the time of DNA immunization also did not
affect the elicitation of long-term T helper responss (Figure 17). For CD4+ T cell
assays, aliquots of the same splenocytes used for CD8+ cell assays were cultured for 2
days with an inactivated influenza virs. Supernatants were harvested, pooled and
assayed for IFNyand IL-5 by ELISA. Results are from a single experiment. As seen
with CD8+ T cell responses
, g.
g. immunized mice had overall higher IFNy production
than the i.m. immunized mice (p, OOO1); For example, following g.g. immunization
IFNy responses ranged from 12 270 pglml to 50,645 pglml, whereas following Lm.
immunization IFNy responses ranged from 1265 pglml to 13,050 pglml The same
phenomenon was seen for IL-5 production (pocO.OOOI). IL-5levels ranged between 880
pglml and 3960 pglml in g.g. DNA-immunized, and between 215 pglml and 835 pglml in
im. immunized mice.
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Maternal antibody inhibits protection from influenza virus challenge.
Maternal antibody inhibited the protective efficacy of DNA immunizations, with
protection correlating with HA-specific IgG (Figure 18, Table 8). All mice DNA
immunized as neonates in the presence of maternal antibody succumbed to
intranasalinfluenza virs challenge as did mice immunized with the control DNA. In
contrast, mice born to naiVe mothers and immunized with HA or HA plus NP DNA were
protected, with codelivery of HA and NP DNAs providing slightly better protection than
HA DNA alone. NP DNA failed to protect any mice, regardless of the presence of NP-
specifc IgG, CD4+ and CD8+ T cell responses.
Young adult DNA- immunized mice born to influenza-immune mothers also were
afforded less protection from influenza virs challenge than mice born to naIve mothers
(Figure 18, Table 8). For instance, adult mice coimmunized with HA plus NP DNAs in
the presence of residual maternal antibody had less than 30% survival; whereas. adult
mice immunized in the absence of maternal antibody had an 80% survival rate. The
levels of protection directly correlated with the levels of anti-HA antibody (Figure 18).
DISCUSSION
We have previously shown in Chapter 1 that immunization of neonatal mice with
influenza HA DNA generates strong, long lasting, protective IgG responses (Pertmer and
Robinson, 1999). In this chapter, we extend these studies to evaluate the effects of
maternal antibody on the effcacy of neonatal DNA immunizations. Our results show
that maternal antibody inhibits the magnitude of IgG responss to HA but not NP (Figure
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Table 8. Effect of maternal antibody on protection from inuenza challenge.
# of survivors 
total tested
Age at time of Immune status Protection
immunization of mother DNA
(%)
1 day Flu-immune HA+NP 017 014
018 014
017 014
Naive HA+NP 3/6 4/7
2/7 2/4
016 014
12 weeks Flu-immune HA+NP 1/4 115
1/4 0/4
0/4 014
Naive HA+NP 4/5 4/5
4/5 1/4
0/4 015
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10, Table 5). They also show that maternal antibody does not interfere with the raising of
CD4+ or CD8+ T cell responses (Figures 14- 17, Table 7). Finally, we show that
protection against a lethal challenge correlates with the presence of antibody to HA
(Table 8, Figure 18). Cellular immune responses in the absence of antibody to HA failed
to protect against influenza challenge (Table 8, Figure 18).
Maternal antibody inhibits IgG responses to HA but not NP
Interestingly, the presence of maternal antibody at the time of DNA immunization
inhibited the generation of antibody responses to HA but not NP (Figure 10, Table 5).
DNA-raised IgG responses to HA were reduced by at least 17-fold, whereas antibody
responses to NP were not significantly affected by the presence of maternal antibody
(Table 5). This was true both for g.g. and im. deliveries of DNA When expressed in a
DNA vaccine, the influenza HA localizes to the plasma membrane, while the influenza
NP is intracellular. This suggests that maternal antibody inhibits the generation of IgG
responses to plasma membrane but not intracellular proteins.
The abilty of maternal antibody to inhibit DNA-raised IgG responses to plasma
membrane, but not intracellular proteins, is consistent with some, but not al, prior
literature (Table 9). The one other study of a DNA-expressed intracellular protein,
LCMV NP, is consistent with our fmdings with influenza NP (Hassett, Zhang, and
Whitton, 1997; Table 5). Thus, in general, intracellular proteins may be protected against
the blocking activity of maternal antibody. Five other studies have been done on the
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Table 9. Studies of neonatal DNA immunization in the presence of maternal antibody.
Type of
rotein Gene Virs Model CTL Reference
Internal LCMV Mouse (Hassett, Zhang, and
Whtton, 1997)
Infuenza Mouse Ths study
Plasma Measles Mouse (Siegrist et at.,
membrane 1998a)
Infuenza Mouse Ths study
Pseudorabies Pig (Le Potier et at.,
1997; Monteil et at.,
1997)
Rabies Mouse (Wang et at., 1998)
Bovine Heres Mouse, (Lewis et at., 1997;
Sheep Van Drnen Littel-
van den Hurk et at.,
1999)
Herpes Mouse (Manickan, Yu, and
Rouse, 1997)
Seceted Tetnus toxin Mouse (Siegrist et at.,
fragment 1998a)
, not done.
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abilty of maternal antibody to block humoral responses to DNA-expressed plasma
membrane proteins (Table 9). These varied in the abilty to raise IgG in the presence of
maternal antibody. Similar to our findings with influenza HA, maternal antibody blocked
DNA-raised IgG responses to measles HA and pseudorabies gD. In contrast, maternal
antibody failed to block DNA raised IgG responses to herpes simplex gB , bovine herpes
gD or rabies glycoprotein (Lewis et ai. 1997; Manickan, Yu, and Rouse, 1997; Van
Drunen Littel-van den Hurk et ai., 1999; Wang et al., 1998; Table 9). The differences in
the abilty of plasma membrane proteins to raise antibody may be due to differences in
the levels of maternal antibody in the different model systems. This is suggested in the
rabies studies where the level of passive antibody affected the extent of blockig (Wang
et ai., 1998). A second, more interesting possibilty would be that plasma membrane
protein differ in how antibody affects their interactions with the immune system. If this
is so, plasma membrane proteins that are sensitive to blocking by maternal antibody may
be able to be engineered for resistance.
In contrast to antibody responses, all DNA-expressed proteins have raisd cell-
mediated immunity in the presence of maternal antibody (Figures 14- 17, Table 7, Table
9). This abilty to raise cellular immunity is independent of the abilty to raise antibody
(Table 9). These fmdings imply that maternal antibody does not block processing and
presentation of DN A-expressed antigens.
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Protection co"elates with antibody titers to HA
In agreement with prior studies HA DNA immunization afforded protection
whereas NP DNA immunization failed to protect against influenza challenge (Figure 18,
Robinson et al. 1997a). The abilty of HA to protect correlated with the level of anti-
antibody (Figure 18). Anti-HA antibody differs from anti-NP antibody or cell-mediated
responses to HA or NP in that it can block virs entry. Thus antibody to HA can limit the
incoming infection. By contrast, CTL to HA and NP are unable to block infection, but
can playa role in the recovery from influenza virs infection. Other groups have shown
protection using NP DNA immunizations (Fu et ai., 1999; Ulmer et al., 1993). These
studies differed from ours in using multiple booster immunizations and challenging with
a relatively low dose of the more attenuated AIK/68 (H3N2) influenza virs (Ulmer 
al., 1993; Montgomery et ai. 1993). In agreement with prior studies, coimmunization
with HA plus NP DNAs had a synergistic effect in enhancing protective immunity (Table
8, Figure 18, (Bot, Bot, and Bona, 1998; Donnelly et al., 1995).
CONCLUSION
We tested the abilty of intramuscular and gene gun immunization with DNA
expressing influenza HA and NP to raie protective humoral and cellular responses in the
presence and absence of maternal antibody. Neonatal mice born to influenza-immune
mothers raised full antibody responses to NP but failed to generate antibody responses to
HA. In contrast, the presence of maternal antibody did not affect the generation of long-
lived CD4+ and CD8+ T cell responses to both HA and NP. Thus, maternal antibody did
110
not affect cell-mediated responses, but rather it limited humoral responses, with the
abilty to limit the antibody response correlating with whether the DNA-expressed
immunogen was localized in the plasma membrane or within the cell.
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SUMRY
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AND
FUTURE DIRECTIONS
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SUMMARY
When this study was initiated, there were three conflcting studies published
regarding DNA immunization of neonatal mice. Two of the studies, in which DNA
expressing measles N (Fooks et ai. 1996) or influenza NP (Bot et ai., 1996) was
inoculated im., had success in eliciting antibody responses. The third study showed
long-term tolerance following Lm. inoculation at birh with DNA expressing the
Plasmodium yoelli (mouse malaria) circumsporozoite protein (Mor et al., 1996). Due to
the importance for vaccination in early life, it was important to determine the
effectiveness of these novel DNA-based vaccines in a neonatal animal model 
wished to investigate whether tolerance was an exception or the rule in neonatal DNA
vaccination. Further, if DNA vaccination was not tolerizing, it was critical to better
characterize the associated DNA-raised immune responses.
The results of this dissertation revealed several important insights regarding Lm.
and g.g. immunization of neonatal mice with HA and/or NP DNAs.
1.) Newborn mice developed stable, long-lived, protective IgG responss similar to
those in adult-immunized mice.
. 2. Unlike adult mice, which developed polaized IgG2a and IgGI responses
following im. and g.g. immunizations, respectively, neonatal mice elicited a
variety of IgGl- , IgG2a- and mixed IgGI/IgG2a responses regardless of the
inoculation method.
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Newborn mice were not able to generate IgG responses following protein subunit
immunization.
Both responsiveness to protein immunization and development of polarized IgG
responses appeared by 2 weeks of age.
Codelivery of Thl genetic adjuvants was capable of shifing the mixed isotype
profies elicited following neonatal DNA immunization to IgG2a-biased
responses.
Codelivery ofThl genetic adjuvants in neonates caused a marked shif towards
production of IFNy.
Maternal antibody inhibited DNA raised IgG responses following HA, but not
, DNA immunization.
Maternal antibody did not inhibit DNA-raised T help or CTL.
Protection from influenza virs challenge following immunization with HA
and/or NP DNAs was dependent on anti-HA-specifc IgG and was independent of
cellular immune responses.
OVERALL DISCUSSION
HVDothesis #1: DNA vaccines are effective in eliciting protective IgG responses in
neonatal mice and can circumvent the Th2-bias normally associated with neonatal
immune responses to other vaccine preparations.
In Chapter 1 , we found that neonatal mice were capable of generating strong,
long-lived, protective IgG responses that were similar in magnitude to those in adult
114
DNA-immunized mice. However, in contrast to the strongly polarized subtype profIes
seen following adult i.m. and g.g. DNA immunization, neonatal mice generated a variety
of IgG 1 , IgG2a and ' mixed' IgG l/IgG2a responses, regardless of immunization method.
Several groups have since shown that DNA immunization with various DNA vaccine
antigens are also capable of eliciting IgG responses (Table 10), with results regarding
isotype patterns being varied (Table 11). Importantly, it is clear that DNA vaccines do
not cause a predominant IgG 1 profIe (indicative of a Th2 type response). Further
temporal studies revealed that development of adult polarized patterns of DNA-raised
IgG subtype responses occurred in mice immunized after 2 weeks of age. These results
were confIrmed by another group (Brazolot Milan et al., 1998).
Hvpothesis #2: The disparity between adult and neonatal DNA-raised IgG responses is
due to a deficiency in ThI-type cytokines at birth, and thus, it is possible to overcome
this deficiency by codelivering ThI genetic adjuvants at the time of DNA
immunization.
In Chapter 2, we found that codelivery ofHA and IL- 12 or IFNyDNA in
neonates elicits predominantly IgG2a responses, while codelivery in adults has no effect
on IgG subtype patterns. Our results also show that codelivery of IL- 12- or IFNy -DNA
in neonates causes a marked shift towards production of IFNy; whereas codelivery of IL-
12 DNA has a much stronger effect than codelivery oflFNy DNA in adults. Very
recently, one other group has assessed the effect ofThl cytokie DNA codelivery on
neonatal DNA-raised T cell responses (Kovarik et al. 2000). This study showed that
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Table 10. Studies on neonatal DNA immunizations in mice.
Protein Method CTL Protection Reference
Murine leukemia Lm. (Butts et al., 1998;
virs gag, pol, env Sarzott et at., 1997)
Heres simplex Lm. (Manickan, Yu, and
virs gB Rouse, 1997)
Infuenza
Lm., g. Chapter 3, (Bot et at.,
1997)
m., g. Chapter 3, (Bot et al.,
1997; Permer and
Robinson, 1999)
LCMV NP Lm. (Hasset, Zhng, and
Whtton, 1997)
Measles
Lm. (Fooks et al., 1996)
Lm. (Marnez et at., 1997)
Rabies virs gp Lm. (Wang et at., 1997; Wang
et al., 1998)
Senda virs NP Lm. (Marnez et al., 1997)
Tetnus toxin C (Marnez et at., 1997)
fra1!ment
, not done
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Table 11. Overview of IgG subtype profies following neonatal DNA immunization.
Protein Method
Herpes simplex im.
virs gB
Hepatitis B l.m.
virs surface
antigen
Influenza HA l.m.
(WSN strai)
Influenza HA Lm., g.
(NPR/8/34)
Influenza NP im., g.
(NPR/8/34)
Tetanus toxin C i.
fragment
Rabies virus gp Lm.
Measles virus im.
Sendai virs im.
IgG profIe
IgG l/IgG2a
Reference
(Manickan, Yu, and Rouse,
1997)
IgG l/IgG2a (Brazolot Milan et al.,
1998)
IgG l/IgG2a (Bot et ai., 1997)
IgG l/IgG2a Chapter 1 , 2
IgG l/IgG2a Chapter 1 , 2
IgG l/IgG2a (Martinez et ai. , 1997)
IgG2a (Wang et ai., 1997)
IgG2a (Marinez et al., 1997)
IgG2a (Marinez et ai., 1997)
Predominant IgG subtype response; IgGl/IgG2a indicates a "mixed" response.
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codelivery of IL- 12 DNA with measles HA caused an increase in IFNy production and a
decrease in IL-5 production, similar to the results presented in Chapter 2. Thus, it may be
possible to supplement neonatal deficiencies with cytokie-expressing DNAs in an effort
to tailor immune responses to DNA vaccine antigens.
Hvpothesis #3: DNA vaccines are effective in generating both humoral and cellular
immune responses in the presence of maternal antibody.
In Chapter 3, we showed that maternal antibody does not interfere with the raising
of CD4+ or CD8-1 T cell responses. We also showed that maternal antibody inhibits the
magnitude of IgG responses to HA but not NP. The abilty of maternal antibody 
inhibit DNA-raised IgG responses to plasma membrane, but not intracellular proteins, is
consistent with some, but not al, prior literature (Table 9). The one other study of 
DNA-expressed intracellular protein, LCMV NP, is consistent with our fmdings with
influenza NP (Hassett, Zhang, and Whitton, 1997). Thus, in general, intracellular
proteins may be protected against the blocking activity of maternal antibody. Similar to
our fmdings with influenza HA, maternal antibody blocked DNA-raised IgG responses to
measles HA and pseudorabies gD. In contrast, maternal antibody failed to block DNA
raised IgG responses to herpes simplex gB , bovine herpes gD or rabies glycoprotein
(Lewis et al., 1997; Manickan, Yu, and Rouse, 1997; Van Drunen Littel-van den Hurk 
al., 1999; Wang et al., 1998; see Table 9).
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FUTURE DIRECTIONS
The work presented in this dissertation wil be relevant to both the fields of DNA
vaccination as well as neonatal immunology in general. Both fields are extremely
complex and many of the very basic studies stil need to be done. The complete picture
of the immaturity of the newborn immune system remains to be elucidated. Mouse
models wil only be of limited utilty in that mice develop at a much more rapid rate than
humans. To add to the complexity, the basic mechanisms behind how DNA vaccines
work are stil unclear, although many groups have been workig on the problem for more
than 7 years. The results presented in this dissertation, as well as other recent studies
suggest DNA vaccines are capable of being used for infant immunization. Although
further studies need to be conducted on the abilty to immunize in the presence of
maternal antibody, this work wil provide rationale for precliical testing of DNA-based
vaccination for various pathogens in larger animal models uch as monkeys.
While several studies have shown the efficacy of neonatal DNA vaccination, only
a handful of groups have addressed the abilty of DNA to vaccinate in the presence of
maternal antibody (Table 9). The abilty to immunize in the presence of maternal
antibody wil be necessary to vaccinate effectively in a cliical setting. As described
previously, maternal antibody interferes with active immunization, and vaccination
protocols are often delayed several months, putting the infant at rik for severe bacterial
and viral infections. Based on results presented here, together with results from other
groups, it appears that some antigens are more affected by the presence of maternal
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antibody than others. For instance, vaccination with DNAs encoding the plasma
membrane proteins of herpes simplex virus gB , bovine herpes virus gD, and rabies virs
gp appear to elicit IgG responses in the presence of maternal antibody; whereas inuenza
virs HA and measles virus HA do not (Table 9).
It is possible that the DNA-expressed plasma membrane proteins may differ in
how antibody affects their interaction with the immune system. One possibilty is that
HA proteins differ, with respect to the other mentioned proteins, in the abilty to undergo
antibody-mediated capping. Capping involves the unipola modulation of surface plasma
membrane proteins. Early studies showed that measles virs plasma membrane proteins
on the cell surface of infected human cells redistributed into pola aggregates following
exposure to measles bivalent antibody in vitro (Joseph and Oldstone, 1975), and further
stripped viral antigen from the cell surface (Oldstone et ai., 1983). Later studies showed
that, lie measles virus HA, influenza HA on the infected cell also capped in the
presence of anti-influenza antibody in vitro (Lydy, Basak, and Compans, 1990), and
further, the capping was due to intrisic properties of the surface glycoprotein itself
(Lydy, Basak, and Compans, 1990). One can visualize a similar scenario occurring in
vivo. If tre, anti-influenza (or -measles) antibody would cap and further strip DNA-
expressed HA from the cell-surface, thereby limiting access of HA to naIve B cells.
The aforementioned studies indicate that influenza HA, measles HA, as well as
other capping-susceptible vaccine plasma membrane proteins (e.g., vesicular stomatitis
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virs G protein or parainfluenza type 3 F protein (Lydy and Compans, 1993)) may be
engineered in the cytoplasmic domain-coding regions using recombinant DNA
technology. It has been suggested that the primary reason why glycoproteins have
differences in the abilty to cap relates to how these proteins are anchored within the cell
membrane. For instance, some glycoproteins may be unable to effectively interact with
host cell components, such as the cytokeleton, via the cytoplasmic domain, thereby
increasing lateral mobilty within the plasma membrane (Lydy and Compans, 1993).
There are two possible ways to apply this theory to potentially overcome the
maternal antibody-inhibiting effect of HA DNA vaccines. First, cloned HA genes can be
truncated to various extents using oligonucleotide-directed mutagenesis via polymeras
chain reaction. Similar cloning strategies have been previously designed to generate
recombinant vaccinia virus vectors expressing a truncated influenza HA (Lydy and
Compans, 1993). This group showed that the truncated HA was expressed at normal
levels at the cell surface but was not capped, thus this strategy provides a reasonable
expectation of success. In a second experiment, cloned HA genes can be engineered to
swap" cytoplasmic and/or transmembane domains of non-capping viral glycoproteins
g., those of herpes gD or rabies glycoprotein to create a chimeric molecule. This can
also be done using standard molecular biology techniques, such as polymerase chain
reaction. Since analogous studies have not previously been attempted, it wil be
necessary to optimize the DNA coding region in terms of each part of the chimeric
molecule. For intance, it may be advantageous to generate DNA that expresses many
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variations of chimeric HA proteins with progressive deletions from the cytoplasmic
domain through the transmembrane anchor domain ofHA. These DNAs can then be
cloned in-frame with DNA encoding progressive substitutions from the transmembrane
domain through the cytoplasmic domain of the secondary non-capping glycoprotein.
Prior to using the truncated HA construct or the chimeric HA construct as a vaccine
mobilty pattern must be checked in vitro in transfected cell using e.
immunofluorescence to determine if, and to what extent, mobilty patterns wil be altered
in the presence of antigen-specific antibody. Furthermore, expression studies using the
truncated or chimeric HA-expressing DNAs must be completed to determine both the
extent of expression and the integrity of the chimeric proteins, which can be also be
achieved using transfected cells in vitro. Once in vitro studies confIrm potential vaccine
candidates for use in the presence of antibody, the DNA(s) can be taken into a
preliinary vaccine trial in vivo. Together, these two experimental strategies provide
guidance in designing an alternative HA DNA vaccine that may be able to be used in the
presence of maternal antibody.
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